
<html lang="en"     class="pb-page"  data-request-id="03c0b1d7-8572-43c3-8898-abfc2634b8ee"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm400186h;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors" /></meta><meta name="dc.Creator" content="Xiaozhang  Zheng" /></meta><meta name="dc.Creator" content="Paul  Bauer" /></meta><meta name="dc.Creator" content="Timm  Baumeister" /></meta><meta name="dc.Creator" content="Alexandre J.  Buckmelter" /></meta><meta name="dc.Creator" content="Maureen  Caligiuri" /></meta><meta name="dc.Creator" content="Karl H.  Clodfelter" /></meta><meta name="dc.Creator" content="Bingsong  Han" /></meta><meta name="dc.Creator" content="Yen-Ching  Ho" /></meta><meta name="dc.Creator" content="Nikolai  Kley" /></meta><meta name="dc.Creator" content="Jian  Lin" /></meta><meta name="dc.Creator" content="Dominic J.  Reynolds" /></meta><meta name="dc.Creator" content="Geeta  Sharma" /></meta><meta name="dc.Creator" content="Chase C.  Smith" /></meta><meta name="dc.Creator" content="Zhongguo  Wang" /></meta><meta name="dc.Creator" content="Peter S.  Dragovich" /></meta><meta name="dc.Creator" content="Angela  Oh" /></meta><meta name="dc.Creator" content="Weiru  Wang" /></meta><meta name="dc.Creator" content="Mark  Zak" /></meta><meta name="dc.Creator" content="Janet  Gunzner-Toste" /></meta><meta name="dc.Creator" content="Guiling  Zhao" /></meta><meta name="dc.Creator" content="Po-wai  Yuen" /></meta><meta name="dc.Creator" content="Kenneth W.  Bair" /></meta><meta name="dc.Description" content="Nicotinamide phosphoribosyltransferase (Nampt) is a promising anticancer target. Virtual screening identified a thiourea analogue, compound 5, as a novel highly potent Nampt inhibitor. Guided by th..." /></meta><meta name="Description" content="Nicotinamide phosphoribosyltransferase (Nampt) is a promising anticancer target. Virtual screening identified a thiourea analogue, compound 5, as a novel highly potent Nampt inhibitor. Guided by th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 13, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400186h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400186h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400186h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400186h" /></link>
        
    
    

<title>Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400186h" /></meta><meta property="og:title" content="Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0028.jpeg" /></meta><meta property="og:description" content="Nicotinamide phosphoribosyltransferase (Nampt) is a promising anticancer target. Virtual screening identified a thiourea analogue, compound 5, as a novel highly potent Nampt inhibitor. Guided by the cocrystal structure of 5, SAR exploration revealed that the corresponding urea compound 7 exhibited similar potency with an improved solubility profile. These studies also indicated that a 3-pyridyl group was the preferred substituent at one inhibitor terminus and also identified a urea moiety as the optimal linker to the remainder of the inhibitor structure. Further SAR optimization of the other inhibitor terminus ultimately yielded compound 50 as a urea-containing Nampt inhibitor which exhibited excellent biochemical and cellular potency (enzyme IC50 = 0.007 μM; A2780 IC50 = 0.032 μM). Compound 50 also showed excellent in vivo antitumor efficacy when dosed orally in an A2780 ovarian tumor xenograft model (TGI of 97% was observed on day 17)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400186h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400186h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400186h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400186h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400186h&amp;href=/doi/10.1021/jm400186h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4921-4937</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400156p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400197m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaozhang++Zheng">Xiaozhang Zheng</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bauer">Paul Bauer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timm++Baumeister">Timm Baumeister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre+J.++Buckmelter">Alexandre J. Buckmelter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maureen++Caligiuri">Maureen Caligiuri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl+H.++Clodfelter">Karl H. Clodfelter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bingsong++Han">Bingsong Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yen-Ching++Ho">Yen-Ching Ho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikolai++Kley">Nikolai Kley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Lin">Jian Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dominic+J.++Reynolds">Dominic J. Reynolds</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Geeta++Sharma">Geeta Sharma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chase+C.++Smith">Chase C. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongguo++Wang">Zhongguo Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+S.++Dragovich">Peter S. Dragovich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Oh">Angela Oh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiru++Wang">Weiru Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Zak">Mark Zak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Gunzner-Toste">Janet Gunzner-Toste</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guiling++Zhao">Guiling Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Po-wai++Yuen">Po-wai Yuen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+W.++Bair">Kenneth W. Bair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Forma Therapeutics, Inc., 500 Arsenal Street, Watertown, Massachusetts 02472, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Pharmaron Beijing, Co. Ltd., 6 Tai He Road, BDA Beijing, 100176, P. R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: 857-209-2382. E-mail: <a href="/cdn-cgi/l/email-protection#532b293b363d3413353c213e32273b362132233626273a30207d303c3e"><span class="__cf_email__" data-cfemail="d2aaa8bab7bcb592b4bda0bfb3a6bab7a0b3a2b7a7a6bbb1a1fcb1bdbf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400186h&amp;href=/doi/10.1021%2Fjm400186h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4921–4937</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 25, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 February 2013</li><li><span class="item_label"><b>Published</b> online</span>13 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400186h" title="DOI URL">https://doi.org/10.1021/jm400186h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4921%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaozhang%2BZheng%252C%2BPaul%2BBauer%252C%2BTimm%2BBaumeister%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D12%26contentID%3Djm400186h%26title%3DStructure-Based%2BIdentification%2Bof%2BUreas%2Bas%2BNovel%2BNicotinamide%2BPhosphoribosyltransferase%2B%2528Nampt%2529%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4937%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400186h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2657</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400186h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaozhang&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bauer&quot;},{&quot;first_name&quot;:&quot;Timm&quot;,&quot;last_name&quot;:&quot;Baumeister&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;J. Buckmelter&quot;},{&quot;first_name&quot;:&quot;Maureen&quot;,&quot;last_name&quot;:&quot;Caligiuri&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;H. Clodfelter&quot;},{&quot;first_name&quot;:&quot;Bingsong&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Yen-Ching&quot;,&quot;last_name&quot;:&quot;Ho&quot;},{&quot;first_name&quot;:&quot;Nikolai&quot;,&quot;last_name&quot;:&quot;Kley&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Dominic&quot;,&quot;last_name&quot;:&quot;J. Reynolds&quot;},{&quot;first_name&quot;:&quot;Geeta&quot;,&quot;last_name&quot;:&quot;Sharma&quot;},{&quot;first_name&quot;:&quot;Chase&quot;,&quot;last_name&quot;:&quot;C. Smith&quot;},{&quot;first_name&quot;:&quot;Zhongguo&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;S. Dragovich&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Oh&quot;},{&quot;first_name&quot;:&quot;Weiru&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Zak&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Gunzner-Toste&quot;},{&quot;first_name&quot;:&quot;Guiling&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Po-wai&quot;,&quot;last_name&quot;:&quot;Yuen&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;W. Bair&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4921-4937&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400186h&quot;},&quot;abstract&quot;:&quot;Nicotinamide phosphoribosyltransferase (Nampt) is a promising anticancer target. Virtual screening identified a thiourea analogue, compound 5, as a novel highly potent Nampt inhibitor. Guided by the cocrystal structure of 5, SAR exploration revealed that the corresponding urea compound 7 exhibited similar potency with an improved solubility profile. These studies also indicated that a 3-pyridyl group was the preferred substituent at one inhibitor terminus and also identified a urea moiety as the optimal linker to the remainder of the inhibitor structure. Further SAR optimization of the other inhibitor terminus ultimately yielded compound 50 as a urea-containing Nampt inhibitor which exhibited excellent biochemical and cellular potency (enzyme IC50 = 0.007 μM; A2780 IC50 = 0.032 μM). Compound 50 also showed excellent in vivo antitumor efficacy when dosed orally in an A2780 ovarian tumor xenograft model (TGI of 97% was observed on day 17).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400186h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400186h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400186h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400186h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400186h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400186h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400186h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400186h&amp;href=/doi/10.1021/jm400186h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400186h" /></input><a href="/doi/pdf/10.1021/jm400186h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400186h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400186h%26sid%3Dliteratum%253Aachs%26pmid%3D23617784%26genre%3Darticle%26aulast%3DZheng%26date%3D2013%26atitle%3DStructure-Based%2BIdentification%2Bof%2BUreas%2Bas%2BNovel%2BNicotinamide%2BPhosphoribosyltransferase%2B%2528Nampt%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D12%26spage%3D4921%26epage%3D4937%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291071" title="Nicotinamide">Nicotinamide</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jmcmar.2013.56.issue-12/production/jmcmar.2013.56.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nicotinamide phosphoribosyltransferase (Nampt) is a promising anticancer target. Virtual screening identified a thiourea analogue, compound <b>5</b>, as a novel highly potent Nampt inhibitor. Guided by the cocrystal structure of <b>5</b>, SAR exploration revealed that the corresponding urea compound <b>7</b> exhibited similar potency with an improved solubility profile. These studies also indicated that a 3-pyridyl group was the preferred substituent at one inhibitor terminus and also identified a urea moiety as the optimal linker to the remainder of the inhibitor structure. Further SAR optimization of the other inhibitor terminus ultimately yielded compound <b>50</b> as a urea-containing Nampt inhibitor which exhibited excellent biochemical and cellular potency (enzyme IC<sub>50</sub> = 0.007 μM; A2780 IC<sub>50</sub> = 0.032 μM). Compound <b>50</b> also showed excellent in vivo antitumor efficacy when dosed orally in an A2780 ovarian tumor xenograft model (TGI of 97% was observed on day 17).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nicotinamide phosphoribosyltransferase (Nampt, NAMPTase, PBEF, Visfatin, EC 2.4.2.12) catalyzes the condensation of nicotinamide (NAM) with 5-phosphoribosyl-1-pyrophosphate (PRPP) to form nicotinamide mononucleotide (NMN), an intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD). In mammalian cells, there are multiple pathways for NAD biosynthesis: a de novo pathway using tryptophan (Trp) as the precursor and three pathways using exogenous vitamin sources as the precursors: NAM, nicotinic acid (NA), and nicotinamide riboside (NR). Nampt is the rate-limiting enzyme in the NAD biosynthetic pathway using NAM. This NAM-dependent pathway is used in cells to recycle the NAM produced by NAD-consuming enzymes such as poly-ADP-ribose polymerases (PARPs) and sirtuins (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Tumors have elevated PARP activity and thereby consume NAD at a higher rate than normal tissues and are thus more dependent upon Nampt to maintain required NAD levels.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> NAD is an essential cofactor in multiple energy producing processes such as mitochondrial oxidative phosphorylation, β oxidation, glycolysis, and the citric acid cycle. Cancer cells have an increased demand for ATP and thus are more sensitive to perturbations of these processes. Rapidly proliferating cancers also have additional biosynthetic requirements that require NAD as a cofactor.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In addition, NAD is essential in maintaining the reductive environment that protects cells from reactive oxygen species (ROS), which are elevated in cancers.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The combination of increased NAD consumption and dependence upon NAD-driven biosynthetic and cellular redox homeostatic processes may make many cancer cells highly dependent on Nampt activity for proliferation and/or survival. Nampt thus represents an attractive target for the development of new cancer therapies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Nampt catalyzed biochemical reaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of NAD biosynthetic pathways found in mammalian cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At the outset of our Nampt program, only three classes of Nampt inhibitors were known in the literature. Fujisawa/TopoTarget’s <b>1</b><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (APO866) and Leo/Gemin-X/Cephalon/Teva’s <b>2</b><a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (GMX1778) were the first two published Nampt inhibitors. <b>1</b> is currently in phase 2 clinical trials against cutaneous T-cell lymphoma (CTCL), while <b>2</b> is in phase 1/2 trials for metastatic melanoma. Triazole-containing compounds were also reported to be potent Nampt inhibitors,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and a representative example, compound <b>3</b>, exhibited an SH-SY5Y cytotoxicity IC<sub>50</sub> value of 93 nM. More recently, Myrexis,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Sanofi-Aventis,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Abbott<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> disclosed additional classes of potent Nampt inhibitors. For example, compound <b>4</b> from Myrexis showed a Nampt enzyme IC<sub>50</sub> of 0.5 nM and HCT116 cytotoxicity of 3.0 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In this paper, we report the identification of highly potent urea-containing small-molecule inhibitors of Nampt, which were designed using the known crystal structure of the enzyme with an inhibitor present. During the course of this work, Myrexis and Sanofi independently reported their own related urea-containing Nampt inhibitors.<a onclick="showRef(event, 'cit8a ref9'); return false;" href="javascript:void(0);" class="ref cit8a ref9">(8a, 9)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reported Nampt inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Structure-Based Identification of a New Chemical Scaffold to Target Nampt</h3><div class="NLM_p">Nampt acts both as a phosphoribosyltransferase and as an ATPase, with phosphorylation of His247 increasing the enzyme’s catalytic activity in a stoichiometric manner.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Structurally, Nampt functions as a homodimer, with two identical catalytic sites located at opposite ends of the dimer interface.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The binding site of ATP overlaps with the PRPP and NAM binding sites. All three sites combine to form a protein surface of >1000 Å<sup>2</sup>, which represents a large area that a potential competitive inhibitor could target. The NAM binding site lies at the entrance to a tunnel through the protein that further extends along the dimer interface to a funnel shaped opening. <b>1</b> occupies this tunnel, with the piperidyl moiety overlapping with the NAM binding site<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Slice through the cocrystal structure of <b>1</b> (yellow) in complex with Nampt (important residues and solvent-excluded-surface in gray) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The crystallographically determined locations of the Nampt substrates NAM (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5C">2E5C</a>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and PRPP (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5D">2E5D</a>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> are also shown (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To pinpoint locations likely to be druggable within these regions, we utilized computational solvent mapping<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> techniques employing CS-Map<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> software. The consensus sites<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in the Nampt binding region were used to define six pharmacophore points (A–F, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) with A and B–C ranking significantly higher than the other three (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Nampt crystal structure depicting virtual fragments which comprise CS-Map consensus sites (carbons in green) and derived pharmacophore points (gray spheres). A = pyridine, B = hydrogen bond acceptor, C = hydrogen bond donor, D = any ring, E = any polar atom, F = any polar atom. Sphere sizes indicate radius of each point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Three pharmacophore models were then created by separately combining the ABC points with one of lower rank (D–F). The resulting models (ABCD, EABC, and FABC) were used to virtually screen the eMolecules database,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> resulting in a set of 228 compounds which were subsequently purchased and tested in our biochemical and cell-based assays. Of the three pharmacophore models, only ABCD yielded compounds with submicromolar anti-Nampt activity. In particular, compound <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) showed a biochemical IC<sub>50</sub> of 0.007 μM and a cellular IC<sub>50</sub> value of 0.19 μM. The cellular activity of compound <b>5</b> was completely reversed by the addition of 0.33 mM of NMN, which proved that the antiproliferation effect was mechanism based. Thus, compound <b>5</b> represented an ideal starting point for additional SAR studies with respect to ligand efficiency (LE = 0.4) and lipophilicity efficiency (LipE = 5.7).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SAR Discussion</h3><div class="NLM_p">To quickly expand SAR around compound <b>5</b>, we identified analogues by chemical fingerprint similarity searches<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and purchased an additional 121 compounds from various commercial sources. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes the biological data generated for selected analogues. Moving the pyridyl nitrogen atom from the 3- to the 4-position (<b>6</b>) was highly detrimental to the anti-Nampt activity. At the other end of the inhibitor structure, removal of the piperidine group led to a 100-fold loss in biochemical potency (<b>7</b>: IC<sub>50</sub> = 0.63 μM), while removal of the entire sulfonamide group (<b>8</b>) led to complete loss of activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationships and Optimization of Hit Compound <b>5</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0018.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0019.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">See Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> for the structures of <b>1</b> and <b>2</b>. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">Simultaneously, in an attempt to better understand how compound <b>5</b> bound to Nampt and to use this information to guide our further SAR optimization, a cocrystal structure of <b>5</b> in complex with the protein was generated (Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). In the NAM-binding region (corresponding to pharmacophore points A, B, and C), the binding mode of compound <b>5</b> was noted to be similar to that observed for <b>1</b> with the pyridyl group stacked between the aromatic side chains of Nampt residues Phe193 and Tyr18′. A crystallographic water was also observed mediating a hydrogen bonding network between the thiourea nitrogens, the backbone carbonyl of Val242, and the Asp219 and Ser241 side chains. The hydroxyl group of Ser275 was located nearly perpendicular to the thiourea moiety of <b>5</b>, and this conformation did not allow for the formation of a typical hydrogen bond with the nearby sulfur atom. Instead, hydrophobic contacts between the sulfur and the side chains of Ile351 and Phe193 were observed. The phenyl ring of <b>5</b> occupied the Nampt tunnel region and participated in an edge-to-face interaction with the side chain of His191. The ligand’s sulfone oxygen atoms filled a hydrophobic pocket formed by the side chains of Ala379, Ile351, and Ile309 but also made hydrogen bonds with crystallographic waters which, in turn, formed other hydrogen bonds to Nampt backbone carbonyl groups. The piperidine moiety of <b>5</b> occupied space close to the piperidine present in <b>1</b> but was situated in a perpendicular orientation. Hydrophobic contacts were noted between the piperidine C2 carbon atom and the side chain of Ile309, as well as between the piperidine C3 and C4 carbons and the Val242 and Pro273 residues.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Co-crystal structure of compound <b>5</b> (green) in complex with Nampt. The ligand binds to a site formed by the interface of two Nampt protein monomers (depicted as white and cyan, respectively). Water molecules are depicted as red spheres, and possible hydrogen bonds are indicated with dashed orange lines. Hydrogen bonds which do not interact with the ligand, either directly or via a water molecule, are not shown. The resolution of the structure is 1.9 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic representation of the binding mode of compound <b>5</b> to Nampt. Waters are depicted as “W” and hydrogen bonds as dashed orange lines. Waters and hydrogen bonds which do not interact with the ligand are not shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To facilitate further optimization, we investigated three distinct areas of these Nampt inhibitors: the left-hand side (LHS), the right-hand side (RHS), and the linker (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Because we were unsure how improvements in one portion would translate to the others, our initial inhibitor design strategy involved concurrent optimization of the various sections to define a preferred pharmacophore. Accordingly, we first chose to optimize the linker region in tandem with the RHS.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nampt inhibitor general structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the cocrystal structure information obtained with compound <b>5</b>, the thiourea sulfur atom did not form a hydrogen bond with the Nampt Ser275 residue (the serine hydroxyl oxygen was within a suitable distance of 3.2 Å but was perpendicular to the thiourea plane). The corresponding urea compound (<b>9</b>) was therefore made to possibly enable a more favorable binding geometry and at the same time reduce compound <b>5</b>’s lipophilicity (calculated ClogP was reduced from 2.4 to 1.5). In fact, compound <b>9</b> exhibited biological potency and microsomal stability similar to that displayed by compound <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and a significantly improved solubility profile (82 vs 3.1 μM). Accordingly, further SAR exploration was focused on molecules containing the urea linker.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Initial SAR Exploration</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0020.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0021.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Aqueous solubility.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">The R-group was linked to the meta-position of the phenyl ring.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last">Above limit of quantification (>100 μM).</p></div><div class="footnote" id="t2fn9"><sup>Table i</sup><p class="last">Below limit of quantification (<0.01 μM). See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">In the cocrystal structure of compound <b>5</b>, the phenyl ring sits in a narrow portion of the tunnel where meta and particularly ortho substitution are sterically restricted by the tunnel walls vs para substitution which points toward the opening. This was confirmed by the meta-attachment of the sulfonamide RHS in compound <b>10</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In the absence of further significant structural guidance for RHS optimization, we initiated general exploratory SAR studies of the RHS with a broad survey of functional group tolerability (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Aryl or heteroarylsulfones (<b>11</b>–<b>13</b>) were found to be equipotent compared to the aliphatic sulfonamide <b>9</b> and also displayed improved mouse microsomal stability. However, the corresponding sulfide was found to exhibit inferior activity in both biochemical and cell-based assays (compare <b>13</b> with <b>14</b>). Similarly, compounds containing ether, ketone, or amide groups in their respective RHS moieties also displayed weaker anti-Nampt properties relative to the sulfones and sulfonamides (<b>15</b>–<b>17</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The importance of maintaining an SO<sub>2</sub> moiety in the inhibitor RHS is likely due to the need to maintain hydrogen bonds to the structural water molecules observed in the Nampt–<b>5</b> cocrystal structure. The attractive biological properties exhibited by the sulfonamide and sulfone-containing inhibitors prompted the inclusion of these functional groups into subsequent Nampt inhibitors.</div><div class="NLM_p">With preliminary RHS SAR information in hand, our focus next turned to exploration of the LHS (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We first examined the importance of the pyridyl nitrogen atom present in compounds <b>9</b> and <b>11</b>. The phenyl analogue corresponding to <b>9</b> (inhibitor <b>18</b>) showed a dramatic loss of potency in both biochemical and cell-based assays. However, moving the nitrogen out of the aromatic ring afforded a compound (<b>19</b>) with similar biochemical potency compared to the related pyridine-containing inhibitor (<b>11</b>). Next, we introduced a fluorine atom at different positions on the phenyl ring in an attempt to mimic the electron-deficient pyridyl moiety present in <b>9</b>. In doing so, we found that 2- or 3-fluoro-substituted compounds (<b>20</b> and <b>21</b>) displayed relatively potent biochemical activities that were much better than that exhibited by the 4-fluoro-substituted compound <b>22</b>. However, all three compounds lacked meaningful cellular activity. Interestingly, introducing a nitrogen atom into the 3-fluoro-benzyl LHS substituent partially restored the lost cell potency (<b>23</b>). These observations emphasized the importance of including an appropriately positioned and sufficiently nucleophilic nitrogen atom in the LHS design with respect to obtaining potent cellular activity. Additional details regarding the biological rationale for this requirement are presented later in this work.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. LHS SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0022.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0023.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">Aqueous solubility.</p></div><div class="footnote" id="t3fn7"><sup>Table g</sup><p class="last">Below limit of quantification (<0.01 μM).</p></div><div class="footnote" id="t3fn8"><sup>Table h</sup><p class="last">Racemic compound. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">Continuing our efforts to search for novel LHS heterocycles, bicyclic LHS compounds were synthesized and tested. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the imidazopyridine LHS compound <b>24</b> improved anti-Nampt cellular potency compared to compound <b>11</b>, but poor MLM stability still remained an issue. When the imidazopyridine system was partially saturated (<b>25</b>), much of the biological activity was lost as compared with compound <b>24</b>. Docking studies of <b>25</b> (not shown) suggested that beneficial π–π interactions were likely impeded by the loss in LHS planarity relative to inhibitor <b>24</b>. The unsaturated ring present in <b>23</b> also required a shift of the linker toward Ser275, which further reduced the efficiency of the hydrogen bond networks in the area. As a follow-on to compound <b>24</b>, we converted the fused bicyclic system into a linked biaryl moiety (compound <b>26</b>). This molecule, however, showed a 10-fold biochemical activity loss, likely due to steric clashes with Nampt residues Tyr195 and Arg196. Replacing the pyridine of <b>11</b> with an alternate heterocycle (e.g., a pyrazole ring; <b>27</b>) resulted in a complete loss of activity. The described exploration identified the 3-pyridyl moiety as a preferred LHS substituent for obtaining both potent biochemical and cellular anti-Nampt activity. Accordingly, this functional group was retained in the inhibitor design throughout the remainder of the SAR studies.</div><div class="NLM_p">We next turned our attention to the linker region (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Given the expected participation of both urea NH groups in an intricate, water-mediated hydrogen-bond network (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), we anticipated that perturbation of either moiety might lead to reduced Nampt inhibition activity. Accordingly, compound <b>28</b> confirmed that NH<sup>β</sup> was critical for biological potency. However, replacing NH<sup>α</sup> with an oxygen (<b>29</b>) or carbon atom (<b>30</b> and <b>32</b>) retained potent biochemical activity while causing a complete loss in cellular potency. The lack of cellular activity exhibited by these molecules may be due to incorrect positioning of the pyridyl nitrogen atom with respect to the PRPP cofactor in the NAMPT active site (see additional discussion below). In contrast, methylation of the NH<sup>α</sup> (<b>31</b>) caused more than a 100-fold loss in biochemical potency compared with compound <b>11</b>. Although the Nampt-<b>5</b> cocrystal structure suggested that space may exist for methylation at the LHS benzylic position, compound <b>33</b> showed that branching at this location was not tolerated.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Linker SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0024.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0025.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">Aqueous solubility.</p></div><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">Not determined.</p></div><div class="footnote" id="t4fn8"><sup>Table h</sup><p class="last">Racemic compound. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">Following this discovery, we examined the effect of varying the linker lengths. As shown by compound <b>34</b>, shortening the linker abolished all activity (compare to compound <b>11</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A one-carbon extension on either side of the urea moiety present in <b>9</b> was somewhat tolerated and afforded similar biochemical activity but also a 5-fold loss of cellular potency (<b>35</b> and <b>36</b>). Transfer of the methylene group of compound <b>9</b> to the right side of the linker (<b>37</b>) led to a roughly 5-fold loss of biochemical activity and almost a complete loss of cellular potency (IC<sub>50</sub> = 2.1 μM) compared to the parent molecule (<b>9</b>). When we replaced the urea moiety present in compound <b>11</b> with the corresponding sulfonylurea, the resulting compound (<b>38</b>) lost almost all biological activity. Additionally, many of the described linker modifications had significant negative impacts on the microsomal stability and solubility of the resulting compounds. For example, inhibitors <b>30</b>–<b>33</b>, <b>35</b>, and <b>38</b> all exhibited inferior metabolic stability toward mouse and/or human liver microsomes relative to the parent compounds <b>9</b> and <b>11</b>. Similarly, inhibitors <b>29</b> and <b>34</b> exhibited drastically reduced solubility as compared with <b>9</b> and <b>11</b>. The origins of these changes are not known with certainty but may involve unfavorable alterations in the lipophilicity and/or hydrogen-bonding potential of the described molecules. The preceding SAR studies confirmed the urea linker moiety present in compounds such as <b>9</b> and <b>11</b> as optimal for obtaining potent anti-Nampt biochemical and cellular activity. This functional group was therefore incorporated into all subsequent inhibitors described in this work.</div><div class="NLM_p">With the completion of LHS and linker region optimizations, we turned our SAR exploration efforts back to the RHS with a focus not only on further potency improvements but also on improving microsomal stability and solubility (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). We first investigated the impact of cyclic sulfonamide variations with respect to these parameters and found that the ring size correlated strongly with enzyme and cellular potency (compounds <b>9</b>, <b>39</b>–<b>41</b>). Although the 7-membered sulfonamide <b>39</b> was comparable to the 6-membered analogue <b>9</b>, it did not offer any advantages with respect to microsomal stability and solubility (<b>39</b> was less stable in MLM and was also less soluble relative to <b>9</b>). In general, aliphatic primary sulfonamides such as compound <b>42</b> were less potent than the cyclic secondary sulfonamides, especially in cell-based assays. Phenyl sulfonamides, such as compound <b>43</b>, did not have good activity and were therefore not extensively explored. Noncyclic secondary sulfonamides such as compound <b>44</b> were also much weaker in the cellular assay relative to the cyclic analogues and were similarly deprioritized.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Sulfonamide RHS SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0026.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0027.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability: % remaining at 30 min.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability: po% remaining at 30 min.</p></div><div class="footnote" id="t5fn6"><sup>Table f</sup><p class="last">Aqueous solubility.</p></div><div class="footnote" id="t5fn7"><sup>Table g</sup><p class="last">% Inhibition was determined at 1 μM concentration.</p></div><div class="footnote" id="t5fn8"><sup>Table h</sup><p class="last">Above limit of quantification (>100 μM).</p></div><div class="footnote" id="t5fn9"><sup>Table i</sup><p class="last">Racemic compound. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">With the above structure–activity relationships in hand, we focused further optimization efforts on piperidine-based sulfonamides (the optimization of biaryl sulfone-containing Nampt inhibitors will be described in a separate disclosure). In general, methyl substitution at the 2-, 3-, or 4-position of the piperidine ring resulted in equivalent cellular potency (compare <b>45</b>–<b>47</b> with <b>9</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). However, the methylated compounds exhibited inferior microsomal stability properties relative to <b>9</b> and additional alkylated piperidines were therefore not pursued. In contrast, introduction of a primary amide at the piperidine 4-position (<b>48</b>) dramatically improved MLM stability compared to <b>9</b>. However, this benefit was realized at the expense of cell potency, possibly due to the highly polar nature of the amide substituent. We therefore prepared the morpholine-containing compound <b>49</b> to test whether incorporation of a less polar electron-withdrawing 4-substituent would also afford good metabolic stability properties. Encouragingly, inhibitor <b>49</b> exhibited improved microsomal stability relative to compound <b>9</b> albeit with a concomitant 7-fold loss in cellular activity. Satisfyingly, a compound containing a bridged morpholine moiety (<b>50</b>) showed an excellent overall profile with respect to biochemical and cellular potency, microsomal stability, and solubility. Compared to the initial lead compound (<b>5</b>), compound <b>50</b> not only maintained excellent ligand efficiency but also greatly improved lipophilicity efficiency (<b>5</b> vs <b>50</b>; LE, 0.4 vs 0.4; LipE, 5.7 vs 7.2, respectively).</div><div class="NLM_p">Given the encouraging biological profile of compound <b>50</b>, the molecule was progressed to in vivo mouse PK and xenograft efficacy studies to evaluate its oral exposure and antitumor effects. As summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, compound <b>50</b> demonstrated reasonable PK properties in mice with oral bioavailability of 26%. It showed a moderate clearance (2.7 ± 0.36 L/h/kg) and a high volume of distribution (1.1 ± 0.22 L/kg). The compound also exhibited maximum plasma exposures that were about 30-fold greater than the corresponding cell IC<sub>50</sub> value, and its plasma levels remained at least 5-fold above this IC<sub>50</sub> for 2 h (all values uncorrected for protein binding effects).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Compound <b>50</b> in Vivo Mean Mouse PK Parameters ± Standard Deviation (SD)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameter</th><th class="colsep0 rowsep0" align="center" char="±">IV 1mg/kg<br /></br>mean (<i>n</i> = 3) ± SD</th><th class="colsep0 rowsep0" align="center">po 5mg/kg<br /></br>mean (<i>n</i> = 3) ± SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub>(h)</td><td class="colsep0 rowsep0" align="char" char="±">0.27 ± 0.03</td><td class="colsep0 rowsep0" align="center">1.3 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">0.08 ± 0.00</td><td class="colsep0 rowsep0" align="center">0.50 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.28</td><td class="colsep0 rowsep0" align="center">1.1 ± 0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub> (μM·h)</td><td class="colsep0 rowsep0" align="char" char="±">0.92 ± 0.11</td><td class="colsep0 rowsep0" align="center">1.4 ± 0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub>(L/kg)</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.22</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.36</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center">26</td></tr></tbody></table></div></div><div class="NLM_p">In an efficacy study, compound <b>50</b> exhibited significant antitumor effects against an A2780 human ovarian carcinoma tumor xenograft model without significant body weight loss. In mice bearing A2780 xenografts, oral administration of the compound for 10 days (125 mg/kg bid) produced rapid tumor regression (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Tumor growth inhibition effects were also noted after cessation of compound dosing during the duration of the xenograft experiment. For example, a tumor growth inhibition value (TGI) of 97% was observed on day 17 of the study. The described xenograft results confirmed that a urea-containing Nampt inhibitor with appropriate biological and DMPK properties can function as a potent in vivo anticancer agent.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Left panel: compound <b>50</b> in vivo efficacy results in A2780 human ovarian carcinoma tumor xenograft model. Right panel: body weight loss as a result of compound <b>50</b> administration in xenograft experiment. Data reflect mean values (±standard deviation) of 8 animals in each group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Phosphoribosylated Adduct Detection and Additional Biochemical Studies</h3><div class="NLM_p">During the LHS SAR optimization process described above, we identified several compounds which exhibited potent inhibition in the Nampt biochemical assay but little activity in the A2780 cell culture assessment (e.g., <b>20</b>–<b>22</b>, <b>29</b>, <b>30</b>, and <b>32</b>). In the case of inhibitors <b>20</b>–<b>22</b>, these outcomes seemed to be associated with the absence of a nucleophilic nitrogen atom in the LHS portions of the molecules. It was previously shown that other Nampt inhibitors bearing similar nucleophilic nitrogen atoms (e.g., compound <b>2</b>) could serve as phosphoribosylation substrates and form adducts with PRPP via a Nampt-catalyzed process.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We suspected that the described urea-containing inhibitors might function in a related manner and therefore conducted detailed mass spectrometry experiments to verify this hypothesis. Accordingly, compound <b>21</b> (a non-nitrogen containing LHS inhibitor devoid of cell activity) and compound <b>50</b> (a nitrogen containing LHS inhibitor with potent cell activity) were incubated with the Nampt enzyme under the standard biochemical assay conditions, and the formation of the corresponding PRPP-derived phosphoribosylated adducts was assessed by LC-MS/MS. The phosphoribosylated adduct was only detected for compound <b>50</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) and was not observed for compound <b>21</b> (data in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Importantly, the <b>50</b>–PRPP adduct was not detected when the Nampt enzyme was omitted from the biochemical experiment, strongly suggesting that the adduct was formed through a Nampt-catalyzed process (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). These results indicate that the ability of a given urea-containing Nampt inhibitor to form a phosphoribosylated adduct may be a necessary requirement for obtaining potent anti-Nampt cell activity.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. LC/MS/MS chromatograms of compound <b>50</b> enzyme reaction mixture: (a) multiple reaction monitoring (MRM) of transition from <i>m</i>/<i>z</i> 615.2 (adduct M + H ion) to 403.2 (parent M + H ion) indicating presence of phosphoribosylated adduct (b) MRM of transition from <i>m</i>/<i>z</i> 403.2 (parent M + H ion) to 135.1 (representing fragmentation of the left-hand side of the parent) indicating presence of both parent (<b>50</b>) and phosphoribosylated adduct. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, the PRPP-derived ribose adducts corresponding to cell-inactive compounds <b>29</b>, <b>30</b>, and <b>32</b> were also detected by mass spectrometry in similar biochemical experiments (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). These data suggest that adduct formation itself is not sufficient to impart potent cell activity to a given Nampt inhibitor and that other factors also influence these outcomes. While compound permeability and protein binding characteristics are two likely determinants of cell potency, we suspected that, due to high structural similarity, these parameters would not vary significantly among the cell potent (<b>50</b>) and cell-inactive (<b>21</b>, <b>29</b>, <b>30</b>, and <b>32</b>) molecules described above. We therefore conducted more detailed biochemical experiments with these compounds in an attempt to better understand their cell culture behavior.</div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, competition experiments indicated that all these molecules inhibit Nampt through a NAM-competitive manner with linear increases in IC<sub>50</sub> values observed with increasing NAM concentrations.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Importantly, varying NAM concentrations had a relatively minor impact on the IC<sub>50</sub> value of the cell active compound (<b>50</b>) as compared with effects on IC<sub>50</sub> outcomes for the other (cell-inactive) molecules studied. This behavior resulted in compound <b>50</b> having the most potent calculated <i>K</i><sub>i</sub> value among these inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Thus, the ability of the compounds and/or their PRPP–ribose adducts to effectively inhibit Nampt in the presence of NAM may also influence their ability to function as potent cell-active agents.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> However, given the similarities between the cell-active molecule <b>50</b> and the cell-inactive compound <b>29</b> in these experiments, it is possible that additional factors also contribute to the cellular outcomes.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effects of varying NAM concentrations on the ability of selected compounds to inhibit Nampt biochemical activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Nampt Biochemical Inhibition Values Determined in the Presence of Various NAM Concentrations</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">Nampt IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">1 μM NAM</th><th class="colsep0 rowsep0" align="center" char=".">5 μM NAM</th><th class="colsep0 rowsep0" align="center" char=".">25 μM NAM</th><th class="colsep0 rowsep0" align="center" char=".">125 μM NAM</th><th class="colsep0 rowsep0" align="center" char=".">250 μM NAM</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub>(μM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.034</td><td class="colsep0 rowsep0" align="char" char=".">0.121</td><td class="colsep0 rowsep0" align="char" char=".">0.756</td><td class="colsep0 rowsep0" align="char" char=".">1.504</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">0.051</td><td class="colsep0 rowsep0" align="char" char=".">0.205</td><td class="colsep0 rowsep0" align="char" char=".">0.525</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="char" char=".">0.082</td><td class="colsep0 rowsep0" align="char" char=".">0.476</td><td class="colsep0 rowsep0" align="char" char=".">1.213</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.064</td><td class="colsep0 rowsep0" align="char" char=".">0.195</td><td class="colsep0 rowsep0" align="char" char=".">1.247</td><td class="colsep0 rowsep0" align="char" char=".">>3.0</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">0.019</td><td class="colsep0 rowsep0" align="char" char=".">0.083</td><td class="colsep0 rowsep0" align="char" char=".">0.171</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Nampt biochemical inhibition. As a result of independent experiments, the IC<sub>50</sub> values determined using 1 μM NAM for the indicated compounds differ slightly from those listed in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Calculated <i>K</i><sub>i</sub> value for each inhibitor (see ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>). Results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p">The urea derivatives were prepared by utilizing the general procedures shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> summarizes the isocyanate approach. Pyridin-3-ylmethanamine <b>51a</b> was condensed with several commercially available isocyanates (<b>52</b>) to give the ureas (<b>15</b>, <b>53</b>, and <b>56</b>). Treatment of the sulfonyl chloride (<b>53</b>) with different amines/anilines (<b>54</b>) then afforded compounds <b>9</b>, <b>39</b>–<b>40</b>, and <b>48</b>–<b>49</b>. To speed up our SAR exploration, a one-step parallel synthesis protocol (reaction of <b>53</b> with <b>54</b>) was also developed to provide the final compounds <b>42</b>–<b>46</b>. Reduction of the sulfonyl chloride group present in intermediate <b>53</b> gave the corresponding sulfinate (<b>55</b>), which was coupled with 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole to provide compound <b>12</b>. Basic hydrolysis of the methyl ester contained in <b>56</b> gave acid <b>57</b>, which was coupled with piperidine to afford final compound <b>17</b>. Alternatively, treatment of various anilines or phenols (<b>58</b>) with triphosgene followed by coupling with benzylic amines or pyridinylmethanamines provided compounds <b>10</b>–<b>11</b>, <b>14</b>, <b>16</b>, <b>18</b>, <b>20</b>–<b>24</b>, <b>26</b>–<b>28</b>, <b>34</b>–<b>37</b>, <b>41</b>, <b>47</b>, <b>50</b>, and <b>59</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Oxidation of the thioether (<b>14</b>) with mCPBA led to compound <b>13</b>. Removal of the Boc protecting group present in intermediate <b>59</b> afforded the final compound <b>19</b>. As shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, condensation of the commercially available aniline <b>58b</b> with various chloroformates (<b>60</b>) formed the corresponding carbamate intermediates (<b>61</b>), which were then coupled with the appropriate alcohols or amines (<b>62</b>) to provide compounds <b>25</b>, <b>29</b>, <b>31</b>, and <b>33</b>. The synthesis of the amide-containing compounds <b>30</b> and <b>32</b> is shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and was accomplished by simply treating aniline <b>58b</b> with the appropriate acid chlorides (<b>63</b>). Coupling of aniline <b>58b</b> with chlorosulfonyl isocyanate and 2-chloroethanol provided the intermediate sulfamoylcarbamate (<b>64</b>), which was then reacted with pyridin-3-ylmethanamine <b>51a</b> to afford the sulfonyl urea (<b>38</b>) as the final compound (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Urea Derivatives Synthesis: Isocyanate Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) THF, −20 to 25 °C, 2 h, 32–95% yield; (ii) THF, 25 °C, 1 h, 14–60% yield; (iii) toluene–CH<sub>2</sub>Cl<sub>2</sub>–DMA, 25–50 °C, 18 h, 17–60% yield; (iv) Na<sub>2</sub>SO<sub>3</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, 80 °C, 3 h, 23% yield; (v) Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, DMSO, 60 °C, 16 h, 31% yield; (vi) LiOH, MeOH, 25 °C, 16 h, 58% yield; (vii) piperidine, BOP, Et<sub>3</sub>N, DMA, 25 °C, 6 h, 45% yield.</p></p></figure><figure id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Urea and Carbamate Derivatives Synthesis: Triphosgene Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> −10 to 25 °C, 16 h, 16–92% yield; (ii) mCPBA, CH<sub>2</sub>Cl<sub>2</sub>–MeOH, 25 °C, 16 h, 15% yield; (iii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 16 h, 58% yield.</p></p></figure><figure id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Urea and Carbamate Derivatives Synthesis: Chloroformate Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-nitrophenyl chloroformate, toluene, 85 °C, 3 h, 100% yield; (ii) phenyl chloroformate, THF, 25 °C, 20 min, 86% yield; (iii) EtOH, reflux, 3 h, 27% yield; (iv) Et<sub>3</sub>N, 1,4-dioxane, 60 °C, 1 h, 61–96% yield.</p></p></figure><figure id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>30</b> and <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 4 h, 33–52% yield.</p></p></figure><figure id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 12 h, 69% yield; (ii) Et<sub>3</sub>N, CH<sub>3</sub>CN, 80 °C, 16 h, 14% yield.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, using structure-based design and leveraging key information from literature-disclosed cocrystal structures, we discovered a structurally novel thiourea-containing Nampt inhibitor (<b>5</b>). Guided by the cocrystal structure of compound <b>5</b> in complex with Nampt, several rounds of SAR optimization ultimately yielded the urea-containing compound <b>50</b>, which possessed excellent cellular potency and in vitro and in vivo ADME properties. Compound <b>50</b> demonstrated reasonable PK properties in mice with an oral bioavailability of 26% and also showed excellent in vivo antitumor efficacy when dosed orally in an A2780 ovarian tumor xenograft model. In addition, SAR and mechanistic studies indicated that an appropriately positioned and sufficiently nucleophilic nitrogen atom was required in the LHS of a given inhibitor to enable Nampt-mediated formation of the corresponding phosphoribosylated (PRPP) adduct and thereby impart potent cellular activity. Further details of related compounds which build on these discoveries will be disclosed in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General</h3><div class="NLM_p last">Unless otherwise indicated, all reagents and solvents were purchased from commercial sources and were used without further purification. Moisture or oxygen sensitive reactions were conducted under an atmosphere of argon or nitrogen gas. Unless otherwise stated, <sup>1</sup>H NMR spectra were recorded at 300 or 400 MHz using Varian or Bruker instruments operating at the indicated frequencies. Chemical shifts are expressed in ppm relative to an internal standard; tetramethylsilane (ppm =0.00). The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, p = pentet, m = multiplet. Purification by silica gel chromatography was carried out using Biotage systems with prepacked cartridges. Chemical purities were >95% for all final compounds as assessed by LCMS analysis at UV 220 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-(3-(Pyridin-3-ylmethyl)ureido)benzene-1-sulfonyl Chloride (<b>53</b>)</h3><div class="NLM_p">4-Isocyanatobenzene-1-sulfonyl chloride (<b>52a</b>; 125 mg, 0.574 mmol) was dissolved in THF (10 mL) and cooled to −20 °C. To this cooled solution was added dropwise a solution of (pyridin-3-yl)methanamine (<b>51a</b>; 62 mg, 0.574 mmol) in THF (6 mL). The mixture was stirred at −20 °C for 5 min and allowed to warm up to room temperature. After stirring for 2 h, Et<sub>2</sub>O (30 mL) was added. The resulting precipitate was collected by filtration to give the title compound (60 mg, 32%). This material was used in the next step without further purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.18 (s, 1H), 8.87–8.76 (m, 2H), 8.60–8.48 (m, 1H), 8.12–8.02 (m, 1H), 7.67–7.58 (m, 1H), 7.48–7.39 (m, 2H), 7.35–7.28 (m, 2H), 4.55–4.43 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.11 min, <i>m</i>/<i>z</i> = 326.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>15</b> and <b>56</b> were synthesized using conditions similar to those employed to make compound <b>53</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(4-Phenoxyphenyl)-3-(pyridin-3-ylmethyl)urea (<b>15</b>)</h3><div class="NLM_p last">Yield 54%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.62 (s, 1H), 8.51 (s, 1H), 8.43 (d, <i>J</i> = 3.3 Hz, 1H), 7.68 (d, <i>J</i> = 7.5 Hz, 1H), 7.43–7.27 (m, 5H), 7.05 (t, <i>J</i> = 7.2 Hz, 1H), 6.94–6.87 (m, 4H), 6.70 (t, <i>J</i> = 6.0 Hz, 1H), 4.30 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.49 min, <i>m</i>/<i>z</i> = 320.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Methyl-4-(3-(pyridin-3-ylmethyl)ureido)benzoate (<b>56</b>)</h3><div class="NLM_p last">Yield 95%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.51–845 (m, 2H), 7.92–7.88 (m, 3H), 7.66–7.79 (m, 1H), 7.42–7.37 (m 2H), 7.29–7.26 (m, 1H), 5.80 (t, <i>J</i> = 6.3 Hz, 1H), 4.42 (d, <i>J</i> = 6.0 Hz, 2H), 3.85 (s, 3H). LCMS (method LCMS1, ESI): RT = 0.71 min, <i>m</i>/<i>z</i> = 286.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-[4-(Piperidine-1-sulfonyl)phenyl]-3-(pyridin-3-ylmethyl)urea (<b>9</b>)</h3><div class="NLM_p"><b>53</b> (60 mg, 0.184 mmol) was suspended in THF (10 mL). To this suspension was added piperidine (<b>54a</b>, 147 mg, 1.72 mmol). The mixture was stirred at room temperature for 1 h. The mixture was then diluted with EtOAc (50 mL), washed with brine (2 × 15 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was crystallized from diethyl ether to afford 40 mg (58%) of the title compound. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.52–8.45 (m, 2H), 7.92 (s, 1H), 7.68 (d, <i>J</i> = 5.0 Hz, 1H), 7.61–7.45 (m, 4H), 7.32–7.27 (m, 1H), 5.80 (t, <i>J</i> = 3.4 Hz, 1H), 4.45 (d, <i>J</i> = 5.7 Hz, 2H), 2.99–2.90 (m, 4H), 1.48–1.75 (m, 4H), 1.42–1.38 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.00 min, <i>m</i>/<i>z</i> = 375.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>39</b>–<b>40</b> and <b>48</b>–<b>49</b> were synthesized using conditions similar to those employed to make compound <b>9</b>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-[4-(Azepane-1-sulfonyl)phenyl]-1-(pyridin-3-ylmethyl)urea (<b>39</b>)</h3><div class="NLM_p last">Yield 38%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.13 (s, 1H), 8.52 (d, <i>J</i> = 1.2 Hz, 1H), 8.45 (dd, <i>J</i> = 1.2, 5.7 Hz, 1H), 7.69 (dt, <i>J</i> = 1.2, 9.0 Hz, 1H), 7.61 (m, 4H), 7.34 (dd, <i>J</i> = 6.0, 12.0 Hz, 1H), 6.88 (t, <i>J</i> = 9.0 Hz, 1H), 4.32 (d, <i>J</i> = 6.0 Hz, 2H), 3.14 (t, <i>J</i> = 6.0 Hz, 4H), 1.58–1.52 (m, 4H), 1.47–1.42 (m, 4H). LCMS (method LCMS1, ESI): RT = 1.11 min, <i>m</i>/<i>z</i> = 389.02 [M + H]<sup>+</sup></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-(Pyridin-3-ylmethyl)-1-[4-(pyrrolidine-1-sulfonyl)phenyl]urea (<b>40</b>)</h3><div class="NLM_p last">Yield 24%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.16 (s, 1H), 8.52 (d, <i>J</i> = 1.2 Hz, 1H), 8.45 (dd, <i>J</i> = 1.2, 5.8 Hz, 1H), 7.70–7.59 (m, 5H), 7.38 (dd, <i>J</i> = 6.0, 12.0 Hz, 1H), 6.90 (t, <i>J</i> = 9.0 Hz, 1H), 4.32 (d, <i>J</i> = 6.0 Hz, 2H), 3.10–3.05 (m, 4H), 1.62–1.60 (m, 4H). LCMS (method LCMS2, ESI): RT = 0.83 min, <i>m</i>/<i>z</i> = 360.98 [M + H]<sup>+</sup></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-[4-(Butylsulfamoyl)phenyl]-1-(pyridin-3-ylmethyl)urea (<b>42</b>)</h3><div class="NLM_p">To a 2 mL reaction vial containing a solution of <i>n</i>-butyl amine in toluene (0.2 M, 400 uL, 80 umol) was add a solution pyridine in CH<sub>2</sub>Cl<sub>2</sub> (1 M, 160 μL, 160 μmol). A solution of (4-(3-(pyridin-3-ylmethyl)ureido)benzene-1-sulfonyl chloride in DMA (0.2 M, 200 μL, 40 umol) was added and the vial was shaken at ambient temperature for 2 h then at 50 °C for 16 h. Methanol (200 uL) was added to the vial, and the mixture was shaken well then transferred to a 0.5 g silica SPE column. The vial was rinsed once with CH<sub>2</sub>Cl<sub>2</sub> (500 μL), and the solution was transferred to the SPE column. The column was eluted once with 10:2.5:1 EtOAc/MeOH/Et<sub>3</sub>N (3 mL), and the eluent was evaporated under reduced pressure. The dark solid obtained was dissolved in DMSO (0.5 mL), and the crude product was purified by preparative HPLC [Waters Autopurification MS-directed HPLC prep fraction collection with the following conditions: column, Xbridge C18 RP 18, 5 μm, 19 mm × 50 mm; flow rate 20 mL/min; mobile phase. Water with 0.1% ammonium hydroxide (A) and methanol with 0.1% ammonium hydroxide (B) running the following gradients: 0–2 min (15% B), 2–6 min (15–100% B). Detector ZQ mass detector in electrospray ionization mode] to give the title compound as a white solid (2.5 mg, 17%). LCMS (method LCMS2, ESI): RT = 0.93 min, <i>m</i>/<i>z</i> = 363.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>43</b>–<b>46</b> were synthesized using the same parallel synthesis conditions employed to make compound <b>42</b>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(4-[Phenylsulfamoyl]phenyl)-1-(pyridin-3-ylmethyl)urea (<b>43</b>)</h3><div class="NLM_p last">Yield 60%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.97 (s, 1H), 9.12 (s, 1H), 7.82 (s, 1H), 7.60 (d, <i>J</i> = 8.4 Hz, 2H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (dd, <i>J</i> = 8.4, 7.3 Hz, 2H), 7.12–7.03 (m, 2H), 7.03–6.96 (m, 1H), 6.93 (s, 1H), 4.41 (s, 2H). LCMS (method LCMS3, ESI): RT = 4.43 min, <i>m</i>/<i>z</i> = 383.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-[4-(Diethylsulfamoyl)phenyl]-1-(pyridin-3-ylmethyl)urea (<b>44</b>)</h3><div class="NLM_p last">Yield 20%. LCMS (method LCMS2, ESI): RT = 0.93 min, <i>m</i>/<i>z</i> = 363.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-{4-[(2-Methylpiperidin-1-yl)sulfonyl]phenyl}-1-(pyridin-3-ylmethyl)urea (<b>45</b>)</h3><div class="NLM_p last">Yield 55%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.48 (d, <i>J</i> = 2.0 Hz, 1H), 8.45 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.28 (s, 1H), 7.66–7.63 (m, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.44 (d, <i>J</i> = 8.8 Hz, 2H), 7.23 (dd, <i>J</i> = 7.6, 4.8 Hz, 1H), 6.15 (t, <i>J</i> = 6 Hz, 1H), 4.39 (d, <i>J</i> = 5.6 Hz, 2H), 4.16–4.07 (m, 1H), 3.60 (dd, <i>J</i> = 13.2, 3.2 Hz, 1H), 2.96–2.89 (m, 1H), 1.55–1.23 (m, 6H), 1.02 (d, <i>J</i> = 6.8 Hz, 3H). LCMS (method LCMS2, ESI): RT: = 1.00 min, <i>m</i>/<i>z</i> = 389.2 [M + 1] <sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-{4-[(3-Methylpiperidin-1-yl)sulfonyl]phenyl}-1-(pyridin-3-ylmethyl)urea (<b>46</b>)</h3><div class="NLM_p last">Yield 20%. LCMS (method LCMS2, ESI): RT = 1.13 min, <i>m</i>/<i>z</i> = 389.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(4-{[(Pyridin-3-ylmethyl)carbamoyl]amino}benzenesulfonyl)piperidine-4-carboxamide (<b>48</b>)</h3><div class="NLM_p last">Yield 14%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.18 (s, 1H), 8.52 (d, <i>J</i> = 3.1 Hz, 1H), 8.48–8.41 (m, 1H), 7.72 (d, <i>J</i> = 7.5 Hz, 1H), 7.64–7.52 (m, 4H), 7.38–7.33 (m, 1H), 7.18 (s, 1H), 6.92 (t, <i>J</i> = 6.0 Hz, 1H), 6.78 (s, 1H), 4.34 (d, <i>J</i> = 6.1 Hz, 2H), 3.50 (d, <i>J</i> = 6.8 Hz, 2H), 2.27–2.18 (m, 2H), 2.08–1.95 (m, 1H), 1.82–1.68 (m, 2H), 1.58–1.42 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.63 min, <i>m</i>/<i>z</i> = 418.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-[4-(Morpholine-4-sulfonyl)phenyl]-3-(pyridin-3-ylmethyl)urea (<b>49</b>)</h3><div class="NLM_p last">Yield 23%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.52 (s, 1H), 7.99 (s, 1H), 7.72 (d, <i>J</i> = 8.1 Hz, 1H), 7.62–7.50 (m 4H), 7.34–7.23 (m, 1H), 5.70 (t, <i>J</i> = 6.3 Hz, 1H), 4.47 (d, <i>J</i> = 6.0 Hz, 2H), 3.78–3.68 (m, 4H), 3.02–2.90 (m, 4H). LCMS (method LCMS1, ESI): RT = 0.63 min, <i>m</i>/<i>z</i> = 377.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Ammonium-4-(3-(pyridin-3-ylmethyl)ureido)benzenesulfinate (<b>55</b>)</h3><div class="NLM_p last"><b>53</b> (3.99 g, 12.25 mmol) was added to a solution of sodium sulfite (6.18 g, 49.0 mmol) and NaHCO<sub>3</sub> (6.17 g, 73.5 mmol) in water (175 mL), and the resulting mixture was stirred at 80 °C for 3 h. The mixture was then concentrated to dryness under reduced pressure, and the resulting solids were triturated with hot DMF (100 mL) and the solids filtered off. The solvent was then removed under reduced pressure, and the resulting residue was triturated with hot DCM (100 mL) and the off-white crystalline solids were collected by vacuum filtration. The solids were purified by SCX ion-exchange column (eluting with 5:1 CH<sub>3</sub>CN/NH<sub>4</sub>OH) to afford the title compound 0.9 g (23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.00 (s, 1H), 8.50 (d, <i>J</i> = 1.2 Hz, 1H), 8.43–8.40 (m, 2H), 8.03 (s, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 7.45 (d, <i>J</i> = 8.0 Hz, 2H), 7.15 (s, br, 4H), 7.02 (t, J = 6.0 Hz, 1H), 4.29 (d, <i>J</i> = 6.0 Hz, 2H) LCMS (method LCMS2, ESI): RT = 0.55 min, <i>m</i>/<i>z</i> = 308.1 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(4-((1-Methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)phenyl)-3-(pyridin-3-ylmethyl)urea (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>53</b> (37 mg, 0.12 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (37 mg, 0.18 mmol), and Et<sub>3</sub>N (0.056 mL, 0.4 mmol) in DMSO (1 mL) was added Cu(OAc)<sub>2</sub> (33 mg, 0.18 mmol). The mixture was stirred at 60 °C for 16 h. Water (8 mL) and EtOAc (8 mL) were added, and the layers were separated. The aqueous layer was extracted with EtOAc (8 mL), and the extract was washed with brine (10 mL), dried, and evaporated. The residue was purified by preparative TLC with 100:7.5:0.75 CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH to give the title compound as an off-white solid (14 mg, 31%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.47 (s, 1H), 8.44 (s, 1H), 8.26 (s, 1H), 7.79 (s, 1H), 7.71–7.65 (m, 4H), 7.43 (d, <i>J</i> = 8.8 Hz, 2H), 7.26–7.23 (m, 1H), 6.12 (t, <i>J</i> = 6.4 Hz, 1H), 4.39 (d, <i>J</i> = 6.0 Hz, 2H), 3.88 (s, 3H). LCMS (method LCMS2, ESI): RT = 0.67 min, <i>m</i>/<i>z</i> = 372.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(3-(Pyridin-3-ylmethyl)ureido)benzoic Acid (<b>57</b>)</h3><div class="NLM_p last"><b>56</b> (750 mg, 2.63 mmol) was treated with LiOH (5.26 mL of a 1.0 M aqueous solution, 5.26 mmol) in MeOH (25 mL) at room temperature for 16 h. The solvent was removed, and the residue was suspended in 20 mL of water and then was washed with EtOAc (3 × 20 mL). The aqueous layer was acidified to pH 4–5 with 1 M HCl. The resulting precipitate was collected, washed with water, and dried to give the desired product (410 mg, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.45 (br, 1H), 9.01 (s, 1H), 8.53 (s, 1H), 8.40 (s, 1H), 7.83–7.75 (m, 2H), 7.71–7.68 (m, 1H), 7.50–7.42 (m, 2H), 7.36–7.28 (m, 1H), 6.85–6.72 (m, 1H), 4.30 (d, <i>J</i> = 6.1 Hz, 2H). LCMS (method LCMS1, ESI): RT = 0.37 min, <i>m</i>/<i>z</i> = 272.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-[4-(Piperidine-1-carbonyl)phenyl]-3-(pyridin-3-ylmethyl)urea (<b>17</b>)</h3><div class="NLM_p last"><b>57</b> (100 mg, 0.369 mmol), piperidine (37.7 mg, 0.442 mmol), and Et<sub>3</sub>N (0.062 mL, 0.442 mmol) were dissolved in DMA (5 mL). To this solution, BOP (196 mg, 0.442 mmol) was added. The mixture was stirred 6 h at room temperature. The reaction mixture was diluted with water (50 mL), and the aqueous layer was back-extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with saturated, aqueous NH<sub>4</sub>Cl (3 × 15 mL), dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the crude product. The crude product was crystallized from EtOAc to afford the title compound (46 mg, 45%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.56–8.42 (m, 2H), 8.02 (s, 1H), 7.71–7.62 (m, 1H), 7.30–7.22 (m, 3H), 7.18–7.08 (m, 2H), 6.30 (t, <i>J</i> = 5.8 Hz, 1H), 4.41(t, <i>J</i> = 6.3 Hz, 2H), 3.40–3.35 (m, 4H), 2.02–1.70 (m, 4H), 1.72–1.60 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.83 min, <i>m</i>/<i>z</i> = 339.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-[3-(Piperidine-1-sulfonyl)phenyl]-3-(pyridin-3-ylmethyl)urea (<b>10</b>)</h3><div class="NLM_p">A solution of 3-(piperidin-1-ylsulfonyl)aniline (<b>58a</b>; 240 mg, 0.999 mmol) and Et<sub>3</sub>N (1.28 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added dropwise to a cooled solution (−10 °C) of triphosgene (98 mg, 0.330 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL). The mixture was stirred for 1 h at room temperature followed by addition of a solution of pyridin-3-ylmethanamine (<b>51a</b>; 108 mg, 0.999 mmol) and Et<sub>3</sub>N (1.28 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The mixture was then stirred for 16 h at room temperature. The reaction was diluted with CH<sub>2</sub>Cl<sub>2</sub> (25 mL), and the organic layer was washed with 1N NaOH, water, and saturated, aqueous NaCl (15 mL). The organic layer was dried with anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the crude product which was purified by Biotage and eluted with 5% MeOH–CH<sub>2</sub>Cl<sub>2</sub>. The collected product was solidified from Et<sub>2</sub>O to offer the desired compound as a white solid (330 mg, 88% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.08 (s, 1H), 8.51 (d, <i>J</i> = 1.8 Hz, 1H), 8.45–8.41 (m, 1H), 7.90 (t, <i>J</i> = 1.8 Hz, 1H), 7.72–7.66 (m, 1H), 7.62–7.56 (m, 1H), 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 737–7.31 (m, 1H), 7.23–7.10 (m, 1H), 6.83 (t, <i>J</i> = 5.7 Hz, 1H), 4.31 (d, <i>J</i> = 5.7 Hz, 2H), 2.87–2.80 (m, 4H), 1.62–1.45 (m, 4H), 1.39–1.30 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.98 min, <i>m</i>/<i>z</i> = 375.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>11</b>, <b>14</b>, <b>16</b>, <b>18</b>, <b>20</b>–<b>24</b>, <b>26</b>–<b>28</b>, <b>34</b>–<b>37</b>, <b>41</b>, <b>47</b>, <b>50</b>, and <b>59</b> were synthesized using conditions similar to those employed to make compound <b>10</b>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-[4-(Benzenesulfonyl)phenyl]-3-(pyridin-3-ylmethyl)urea (<b>11</b>)</h3><div class="NLM_p last">Yield 55% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.20 (s, 1H), 8.55–8.49 (m, 1H), 8.45–8.40 (m, 1H), 7.90–7.81 (m, 2H), 7.80–7.65 (m, 2H), 7.70–7.54 (m, 6H), 7.35–7.26 (m, 1H), 6.89 (t, <i>J</i> = 5.7 Hz, 1H), 4.30 (d, <i>J</i> = 6.0 Hz, 2H), LCMS (method LCMS1, ESI): RT = 0.95 min, <i>m</i>/<i>z</i> = 368.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(4-((4-Chlorophenyl)thio)phenyl)-3-(pyridin-3-ylmethyl)urea (<b>14</b>)</h3><div class="NLM_p last">Yield 43%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.90 (s, 1H), 8.52–8.50 (m, 1H), 8.45–8.43 (m, 1H), 7.71–7.67 (m, 1H), 7.51–7.46 (m, 2H), 7.37–7.31 (m, 5H), 7.11–7.06 (m, 2H), 6.81 (t, <i>J</i> = 6.0 Hz, 1H), 4.30 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 2.79 min, <i>m</i>/<i>z</i> = 370.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(4-Benzoylphenyl)-3-(pyridin-3-ylmethyl)urea (<b>16</b>)</h3><div class="NLM_p last">Yield 45%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.16 (s, 1H), 8.53 (s, 1H), 8.45 (s, 1H), 9.72–7.50 (m, 10H), 7.38–7.31 (m, 1H), 6.88 (t, <i>J</i> = 5.1 Hz, 1H), 4.36 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.61 min, <i>m</i>/<i>z</i> = 332.09 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-Benzyl-1-[4-(piperidine-1-sulfonyl)phenyl]urea (<b>18</b>)</h3><div class="NLM_p last">Yield 46%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.11 (s, 1H), 7.64–7.51 (m, 4H), 7.35–7.21 (m, 5H), 6.81 (t, <i>J</i> = 6.0 Hz, 1H), 4.30 (d, <i>J</i> = 6.0 Hz, 2H), 2.83–2.76 (m, 4H), 1.56–1.45 (m, 4H), 1.34–1.28 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.50 min, <i>m</i>/<i>z</i> = 374.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-[(2-Fluorophenyl)methyl]-1-[4-(piperidine-1-sulfonyl)phenyl]urea (<b>20</b>)</h3><div class="NLM_p last">Yield 78%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.14 (s, 1H), 7.62–7.51 (m, 4H), 7.38–7.25 (m, 2H), 7.20–7.12 (m, 2H), 6.82 (t, <i>J</i> = 5.8 Hz, 1H), 4.34 (d, <i>J</i> = 6.0 Hz, 2H), 2.83–2.75 (m, 4H), 1.55–1.45 (m, 4H), 1.34–1.27 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.51 min, <i>m</i>/<i>z</i> = 392.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-[(3-Fluorophenyl)methyl]-1-[4-(piperidine-1-sulfonyl)phenyl]urea (<b>21</b>)</h3><div class="NLM_p last">Yield 71%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.17 (s, 1H), 7.65–7.51 (m, 4H), 7.40–7.31 (m, 1H), 7.14–7.01 (m, 3H), 6.88 (t, <i>J</i> = 5.8 Hz, 1H), 4.31 (d, <i>J</i> = 5.7 Hz, 2H), 2.83–2.76 (m, 4H), 1.53–1.46 (m, 4H), 1.35–1.29 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.52 min, <i>m</i>/<i>z</i> = 392.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-[(4-Fluorophenyl)methyl]-3-[4-(piperidine-1-sulfonyl)phenyl]urea (<b>22</b>)</h3><div class="NLM_p last">Yield 92%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.13 (s, 1H), 7.64–7.55 (m, 4H), 7.36–7.31 (m, 2H), 7.18–7.13 (m 2H), 6.85–6.81 (m, 1H), 4.30–4.28 (d, <i>J</i> = 5.7 Hz, 2H), 2.84–2.79 (m, 4H), 1.53–1.50 (m, 4H), 1.34–1.32 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.51 min, <i>m</i>/<i>z</i> = 392.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-[(5-Fluoropyridin-3-yl)methyl]-1-[4-(piperidine-1-sulfonyl)phenyl]urea (<b>23</b>)</h3><div class="NLM_p last">Yield 92%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.23 (s, 1H), 8.42 (dd, <i>J</i> = 2.7 Hz, <i>J</i> = 14.4 Hz, 2H), 7.59–7.53 (m, 5H), 6.95 (t, <i>J</i> = 6 Hz, 1H), 4.36 (d, <i>J</i> = 6 Hz 2H), 2.82–2.78 (m, 4H), 1.56–1.46 (m, 4H), 1.38–1.24 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.31 min, <i>m</i>/<i>z</i> = 393.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-[4-(Benzenesulfonyl)phenyl]-3-{imidazo[1,2-a]pyridin-6-ylmethyl}urea (<b>24</b>)</h3><div class="NLM_p last">Yield 64%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.20 (s, 1H), 8.43 (s, 1H), 7.92–7.86 (m, 3H), 7.81–7.77 (m, 2H), 7.64–7.49 (m, 7H), 7.20–7.15 (m, 1H), 6.90–6.84 (m, 1H), 4.30–4.26 (m, 2H). LCMS (method LCMS1, ESI) RT = 0.94 min, <i>m</i>/<i>z</i> = 407.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-[4-(Benzenesulfonyl)phenyl]-1-{[6-(1<i>H</i>-imidazol-1-yl)pyridin-3-yl]methyl}urea (<b>26</b>)</h3><div class="NLM_p last">Yield 17%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 8.25 (s, 1H), 8.13 (s, 1H), 7.89–7.86 (m, 2H), 7.77–7.71 (m, 3H), 7.59 (s, 1H), 7.59–7.43 (m, 5H), 7.21–7.17 (m, 2H), 6.08 (s, 1H), 4.43 (d, <i>J</i> = 6 Hz, 2H). LCMS (method LCMS1, ESI): RT = 0.98 min, <i>m</i>/<i>z</i> = 434.2 [M + H]<sup>+</sup></div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-[4-(Benzenesulfonyl)phenyl]-3-(1<i>H</i>-pyrazol-3-ylmethyl)urea (<b>27</b>)</h3><div class="NLM_p last">Yield 53%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.60 (s, 1H), 9.11 (s, 1H), 7.90–7.86 (m, 2H), 7.81–7.77 (m, 2H), 7.65–7.55 (m, 6H), 6.67–6.63 (m, 1H), 6.27–6.24 (m, 1H), 4.25–4.21 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.74 min, <i>m</i>/<i>z</i> = 357.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-(Piperidine-1-sulfonyl)phenyl <i>N</i>-(Pyridin-3-ylmethyl)carbamate (<b>28</b>)</h3><div class="NLM_p last">Yield 45%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.60–8.49 (m, 2H), 7.73–7.70 (m, 3H), 7.31–7.26 (m, 3H), 6.09 (s, 1H), 4.45 (d, <i>J</i> = 6.0 Hz, 2H), 2.97–2.94 (m, 4H), 1.75–1.55 (m, 4H), 1.52–1.39 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.43 min, <i>m</i>/<i>z</i> = 376.06 [M + H]<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-[4-(Benzenesulfonyl)phenyl]-1-(pyridin-3-yl)urea (<b>34</b>)</h3><div class="NLM_p last">Yield 34%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.36 (s, 1H), 9.00 (s, 1H), 8.59 (d, <i>J</i> = 2.4 Hz, 1H), 8.20 (dd, <i>J</i> = 4.5, 1.2 Hz, 1H), 7.95–7.82 (m, 5H), 7.69–7.52 (m, 5H), 7.33–7.27 (m, 1H). LCMS (method LCMS1, ESI): RT = 1.07 min, <i>m</i>/<i>z</i> = 354.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-[4-(Piperidine-1-sulfonyl)phenyl]-1-[2-(pyridin-3-yl)ethyl]urea (<b>35</b>)</h3><div class="NLM_p last">Yield 57%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.00 (s, 1H), 8.44–8.40 (m, 2H), 7.67–7.66 (m, 1H), 7.60–7.52 (m, 4H), 7.34–7.30 (m, 1H), 6.34 (t, <i>J</i> = 5.7 Hz, 1H), 3.39–3.35 (m, 2H), 2.82–2.52 (m, 6H), 1.56–1.48 (m, 4H), 1.32–1.33 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.99 min, <i>m</i>/<i>z</i> = 389.03 [M + H]<sup>+</sup></div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}-1-(pyridin-3-ylmethyl)urea (<b>36</b>)</h3><div class="NLM_p last">Yield 20%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.45 (s, 1H), 8.49–8.42 (m, 1H), 7.68–7.59 (m, 3H), 7.45 (d, <i>J</i> = 3.0 Hz, 2H), 7.33–7.29 (m, 1H), 6.71–6.60 (m, 2H), 4.31 (d, <i>J</i> = 5.7 Hz, 2H), 4.23 (d, <i>J</i> = 5.7 Hz, 2H), 2.85–2.82 (m, 4H), 1.53–1.48 (m, 4H), 1.35–1.29 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.95 min, <i>m</i>/<i>z</i> = 389.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}-1-(pyridin-3-yl)urea (<b>37</b>)</h3><div class="NLM_p last">Yield 68%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.90 (s, 1H), 8.54 (m, 1H), 8.11 (dd, <i>J</i> = 1.2, 4.5 Hz, 1H), 7.92–7.85 (m, 1H), 7.70–7.64 (m, 2H), 7.54–7.49 (m, 2H), 7.27–7.20 (m, 1H), 6.91 (t, <i>J</i> = 5.7 Hz, 1H), 4.40 (d, <i>J</i> = 6.0 Hz, 2H), 2.88–2.79 (m, 4H), 1.55–1.47 (m, 4H), 1.35–1.30 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.01 min, <i>m</i>/<i>z</i> = 375.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-[4-(Azetidine-1-sulfonyl)phenyl]-1-(pyridin-3-ylmethyl)urea (<b>41</b>)</h3><div class="NLM_p last">Yield 43%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.26 (s, 1H), 8.52 (d, <i>J</i> = 2.1 Hz, 1H), 8.44 (dd, <i>J</i> = 1.8, 4.8 Hz 1H), 7.66–7.58 (m, 5H), 7.37–7.32 (m, 1H), 6.95 (t, <i>J</i> = 6.3 Hz, 1H), 4.33 (d, <i>J</i> = 6.3 Hz, 2H), 3.58 (t, <i>J</i> = 7.8 Hz 4H), 1.96–1.91 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.72 min, <i>m</i>/<i>z</i> = 347.14 [M + H]<sup>+</sup></div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-{4-[(4-Methylpiperidin-1-yl)sulfonyl]phenyl}-1-(pyridin-3-ylmethyl)urea (<b>47</b>)</h3><div class="NLM_p last">Yield 16%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.17 (s, 1H), 8.51 (s, 1H), 8.45–8.43 (m, 1H), 7.71–7.67 (m, 1H), 7.62–7.53 (m, 4H), 7.36–7.32 (m, 1H), 6.92–6.89 (m, 1H), 4.31 (d, <i>J</i> = 6.3 Hz, 2H), 3.53 (d, <i>J</i> = 11.4 Hz, 2H), 2.11–2.04 (m, 2H), 1.65–1.57 (m, 2H), 1.22–1.18 (m, 1H), 1.12–1.05 (m, 2H), 0.82 (d, <i>J</i> = 6.3 Hz, 3H). LCMS (method LCMS1, ESI): RT = 0.99 min, <i>m</i>/<i>z</i> 389.03 [M + H]<sup>+</sup></div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-(4-{8-Oxa-3-azabicyclo[3.2.1]octane-3-sulfonyl}phenyl)-3-(pyridin-3-ylmethyl)urea (<b>50</b>)</h3><div class="NLM_p last">Yield 78%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.20 (s, 1H), 8.52 (d, <i>J</i> = 2.1 Hz, 1H), 8.46–8.42 (m, 1H), 7.72–7.67 (m, 1H), 7.64 (d, <i>J</i> = 9.0 Hz, 2H), 7.54 (d, <i>J</i> = 9.0 Hz, 2H), 7.38–7.30 (m, 1H), 6.92 (t, <i>J</i> = 6.0 Hz, 1H), 4.32 (d, <i>J</i> = 6.0 Hz, 4H), 3.20 (d, <i>J</i> = 11.1 Hz, 2H), 2.38 (d, <i>J</i> = 9.3 Hz, 2H), 1.75 (s, br,, 4H). LCMS (method LCMS1, ESI): RT = 1.11 min, <i>m</i>/<i>z</i> = 403.14 [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl-3-((3-(4-(phenylsulfonyl)phenyl)ureido)methyl)phenylcarbamate (<b>59</b>)</h3><div class="NLM_p last">Yield 85%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.87–7.82 (m, 2H), 7.73–7.65 (m, 2H), 7.52–7.42 (m, 4H), 7.40–7.37 (m, 2H), 7.29 (s, 1H), 7.15–7.10 (m, 2H), 6.88–6.84 (m, 1H), 6.65 (s, 1H), 5.51 (t, <i>J</i> = 5.7 Hz, 1H), 4.24 (d, <i>J</i> = 5.7 Hz, 2H), 1.47 (s, 9H). LCMS (method LCMS1, ESI): RT = 2.24 min, <i>m</i>/<i>z</i> = 482.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-[(3-Aminophenyl)methyl]-1-[4-(benzenesulfonyl)phenyl]urea (<b>19</b>)</h3><div class="NLM_p last">A solution of <b>59</b> (390 mg, 0.810 mmol) and trifluoroacetic acid (5 mL, 64.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was stirred at ambient temperature for 16 h. The mixture was concentrated and partitioned between CH<sub>2</sub>Cl<sub>2</sub> and saturated NaHCO<sub>3</sub>. The organic layer was washed with brine (2 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by Biotage using 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to offer the title compound (180 mg, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.12 (s, 1H), 8.55–8.49 (m, 2H), 8.45–8.40 (m, 2H), 7.90–7.81 (m, 5H), 6.90 (t, <i>J</i> = 7.6 Hz, 1H), 6.69 (t, <i>J</i> = 5.8 Hz, 1H), 6.50–6.40 (m, 3H), 5.41 (br, s, 2H), 4.13 (d, <i>J</i> = 5.7 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.16 min, <i>m</i>/<i>z</i> = 382.28 [M + H]<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-[4-(4-Chlorobenzenesulfonyl)phenyl]-1-(pyridin-3-ylmethyl)urea (<b>13</b>)</h3><div class="NLM_p last">A solution of <b>14</b> (50 mg, 0.135 mmol) in 10:1 CH<sub>2</sub>Cl<sub>2</sub>:MeOH (3.3 mL) was treated with mCPBA (62 mg, 0.270 mmol), and the solution was stirred for 16 h at ambient temperature. The mixture was then diluted with saturated NaHCO<sub>3</sub> (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and the layers separated. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparatory TLC (6% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to obtain the title compound (8 mg, 15%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.24 (s, 1H), 8.49 (s, 1H), 8.43–8.42 (m, 1H), 7.90–7.86 (m, 2H), 7.81–7.77 (m, 2H), 7.68–7.58 (m, 5H), 7.35–7.31 (m, 1H), 6.92 (t, <i>J</i> = 6.0 Hz, 1H), 4.30 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.69 min, <i>m</i>/<i>z</i> = 402.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 4-Nitrophenyl-<i>N</i>-[4-(benzenesulfonyl)phenyl]carbamate (<b>61a</b>)</h3><div class="NLM_p last">A solution of 4-(benzenesulfonyl)aniline (<b>58b</b>; 300 mg, 1.29 mmol) and 4-nitrophenyl chloroformate (<b>60a</b>; 310.6 mg, 1.54 mmol) in toluene (10 mL) was stirred at 85 °C for 3 h. The resulting mixture was concentrated under vacuum to give 620 mg (>100%) of crude product as an off-white solid, which was used for next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.97 (s, 1H), 8.35 (d, <i>J</i> = 9.2 Hz, 2H), 8.10–7.90 (m, 4H), 7.80–7.50 (m, 7H).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Pyridin-3-ylmethyl <i>N</i>-[4-(Benzenesulfonyl)phenyl]carbamate (<b>29</b>)</h3><div class="NLM_p last">A solution of pyridin-3-ylmethanol (<b>62a</b>; 80 mg, 0.73 mmol) and <b>61a</b> (292 mg, 0.73 mmol) in ethanol (4 mL) was refluxed for 3 h. The reaction mixture was cooled to room temperature and concentrated under vacuum. The residue was purified by Prep-HPLC with the following conditions: Column, Xbridge Shield RP 18, 5 um, 19 mm × 150 mm; mobile phase, water with 50 mmol NH<sub>4</sub>HCO<sub>3</sub> and CH<sub>3</sub>CN (10.0% CH<sub>3</sub>CN up to 28.0% in 2 min, up to 46.0% in 10 min, up to 100.0% in 1 min, down to 10.0% in 1 min). Detector, UV 254 nm to give 73.7 mg (27%) of the desired compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.58–8.52 (m, 2H), 7.73–7.70 (m, 3H), 7.29–7.26 (m, 3H), 6.09 (s, 1H), 4.45 (d, <i>J</i> = 6 Hz, 2H), 2.97–2.93 (m, 4H), 1.70–1.56 (m. 4H), 1.41–1.38 (m, 2H). LCMS (method LCMS3, ESI): RT = 1.43 min, <i>m</i>/<i>z</i> = 369.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Phenyl-(4-(phenylsulfonyl)phenyl)carbamate (<b>61b</b>)</h3><div class="NLM_p last">To the mixture of 4-(benzenesulfonyl)aniline (<b>58b</b>; 0.6 g, 2.57 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.4 g, 10.3 mmol) in THF (15 mL) was added phenyl carbonochloridate (<b>60b</b>; 2.0 g, 12.9 mmol). The reaction mixture was stirred at room temperature for 20 min and then was concentrated to half volume under vacuum. Water (10 mL) and brine (5 mL) were added to the reaction mixture and the product precipitated as a solid. The crude white solid was collected by filtration, washed twice with Et<sub>2</sub>O, and dried under high vacuum to yield the title compound (0.78 g, 86%). This material was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.72 (s, 1H), 7.96–7.88 (m, 4H), 7.76–7.57 (m, 5H), 7.43 (t, <i>J</i> = 7.7 Hz, 2H), 7.31–7.19 (m, 3H). LCMS (method LCMS4, ESI): RT = 0.83 min, <i>m</i>/<i>z</i> = 234.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-[4-(Benzenesulfonyl)phenyl]-1-methyl-1-(pyridin-3-ylmethyl)urea (<b>31</b>)</h3><div class="NLM_p last">To <i>N</i>-methyl-1-(pyridin-3-yl)methanamine (<b>62b</b>; 17 mg, 0.140 mmol) and Et<sub>3</sub>N (0.06 mL, 0.42 mmol) in 1,4-dioxane (1 mL) was added <b>61b</b> (50 mg, 0.140 mmol), and the reaction was heated to 60 °C for 1 h. The compound was purified by preparative HPLC (column, Gemini-NX, 3 cm × 10 cm, 10 μm; detection: UV 254 nm; mobile phase A, H<sub>2</sub>O containing 0.1% NH<sub>4</sub>OH; mobile phase B, acetonitrile; flow rate, 60 mL/min; gradient, 0–1 min 5% B, 1–10 min. 5–50% B, 10–11 min, 50% B, 11–11.2 min, 50–95% B, 11.2–13 min, 95% B, 13–13.2 min, 95–5% B, 13.2–15 min, 5% B). Isolation and concentration of the appropriate fractions afforded the title compound as a white solid (49 mg, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.93 (s, 1H), 8.54–8.44 (m, 2H), 7.90 (dd, <i>J</i> = 7.3, 1.8 Hz, 2H), 7.82 (d, <i>J</i> = 8.8 Hz, 2H), 7.73 (d, <i>J</i> = 8.9 Hz, 2H), 7.70–7.63 (m, 2H), 7.60 (dd, <i>J</i> = 8.3, 6.7 Hz, 2H), 7.37 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 4.57 (s, 2H), 2.96 (s, 3H). LCMS (method LCMS5, ESI): RT = 3.35 min, <i>m</i>/<i>z</i> = 382.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-[4-(Benzenesulfonyl)phenyl]-3-{5<i>H</i>,6<i>H</i>,7<i>H</i>,8<i>H</i>-imidazo[1,2-<i>a</i>]pyridin-6-ylmethyl}urea (<b>25</b>)</h3><div class="NLM_p last">This compound was synthesized using conditions similar to those employed to make compound <b>31</b>. Yield 61%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.08 (s, 1H), 7.90–7.85 (m, 2H), 7.80–7.75 (m, 2H), 7.64–7.55 (m, 5H), 6.97 (d, <i>J</i> = 6.0 Hz, 1H), 6.79 (d, <i>J</i> = 6.0 Hz, 1H), 6.57–6.52 (m, 1H), 4.05–3.98 (m, 1H), 3.60–3.52 (m, 1H), 3.18–3.14 (m, 2H), 2.79–2.75 (m, 1H), 2.68–2.63 (m, 1H), 2.16–2.06 (m, 1H), 1.97–1.88 (m, 1H), 1.60–1.48 (m, 1H). LCMS (method LCMS1, ESI): RT = 1.30 min, <i>m</i>/<i>z</i> = 411.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-[4-(Benzenesulfonyl)phenyl]-1-[1-(pyridin-3-yl)ethyl]urea (<b>33</b>)</h3><div class="NLM_p last">This compound was synthesized using conditions similar to those employed to make compound <b>31</b>, 52 mg, 96% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.05 (s, 1H), 8.56 (d, <i>J</i> = 2.2 Hz, 1H), 8.44 (dd, <i>J</i> = 4.7, 1.4 Hz, 1H), 7.93–7.83 (m, 2H), 7.78 (d, <i>J</i> = 8.7 Hz, 2H), 7.73 (dt, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.65 (t, <i>J</i> = 7.2 Hz, 1H), 7.62–7.51 (m, 4H), 7.35 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.00 (d, <i>J</i> = 7.6 Hz, 1H), 4.84 (p, <i>J</i> = 7.1 Hz, 1H), 1.42 (d, <i>J</i> = 7.0 Hz, 3H). LCMS (method LCMS5, ESI): RT = 3.41 min, <i>m</i>/<i>z</i> = 382.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-[4-(Benzenesulfonyl)phenyl]-2-(pyridin-3-yloxy)acetamide (<b>30</b>)</h3><div class="NLM_p last">A mixture of 2-(pyridin-3-yloxy)acetyl chloride (110 mg, 0.64 mmol), 4-(benzenesulfonyl)aniline (<b>58b</b>, 150 mg, 0.64 mmol), and Et<sub>3</sub>N (190 mg, 1.88 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at room temperature for 4 h. The reaction mixture was quenched with 5 mL of H<sub>2</sub>O and then extracted with 3 × 10 mL of CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under vacuum. The crude product was purified by Prep-HPLC with the following conditions: column, SunFire Prep C18, 19 mm × 150 mm 5 μm; mobile phase, water with 0.05% NH<sub>4</sub>HCO<sub>3</sub> and CH<sub>3</sub>CN (5% CH<sub>3</sub>CN up to 43% in 7 min).Detector, UV 254 nm to give 79.1 mg (33%) of the title compound as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 8.40 (s, 1H), 8.20 (d, <i>J</i> = 4.5 Hz, 1H), 7.97–7.86 (m, 6H), 7.78–7.50 (m, 4H), 7.39 (m, 1H), 4.81 (s, 2H). LCMS (LCMS6, ESI): RT = 1.83 min, <i>m</i>/<i>z</i> = 369.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-[4-(Benzenesulfonyl)phenyl]-3-(pyridin-3-yl)propanamide (<b>32</b>)</h3><div class="NLM_p last">A mixture of 4-(benzenesulfonyl)aniline (<b>58b</b>, 100 mg, 0.43 mmol), 3-(pyridin-3-yl)propanoyl chloride hydrochloride (88 mg, 0.43 mmol), and Et<sub>3</sub>N (130 mg, 1.28 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was refluxed for 3 h. The reaction mixture was concentrated under vacuum, and the crude product was purified by Prep-HPLC with the following conditions: Column, Xbridge Shield RP 18, 5 um, 19 mm × 150 mm; mobile phase, water with 50 mmol NH<sub>4</sub>HCO<sub>3</sub> and CH<sub>3</sub>CN (10.0% CH<sub>3</sub>CN up to 28.0% in 2 min, up to 46.0% in 10 min, up to 100.0% in 1 min, down to 10.0% in 1 min). Detector, UV 254 nm to give 82.1 mg (52%) of the title compound as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.57 (s, 1H), 8.46 (s, 1H), 8.33 (s, 1H), 7.97–7.87 (m, 4H), 7.68 7.59 (m, 3H), 7.55–7.48 (m, 3H), 7.30–7.37 (m, 1H), 3.06 (t, <i>J</i> = 7.2 Hz, 2H), 2.72 (t, <i>J</i> = 7.5 Hz, 2H). LCMS (method LCMS6, ESI): RT = 1.35 min, <i>m</i>/<i>z</i> = 367.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Chloroethyl-<i>N</i>-(4-(phenylsulfonyl)phenyl)sulfamoylcarbamate (<b>64</b>)</h3><div class="NLM_p last">Sulfurisocyanatidic chloride (0.283 g, 2.00 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and cooled to 0 °C. To this cooled solution was added 2-chloroethanol (0.161 g, 2.00 mmol), and the mixture was stirred at 0–5 °C for 1.5 h. A suspension of 4-(benzenesulfonyl)aniline (<b>58b</b>, 0.467 g, 2.00 mmol) and Et<sub>3</sub>N (0.279 mL, 2.00 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added, and the resulting mixture was warmed to room temperature and stirred for 12 h. The reaction was quenched with 1N HCl to pH = 7. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude material thus obtained was used in the next step without further purification (0.76 g, 69% yield). LCMS (method LCMS1, ESI): RT = 1.75 min, <i>m</i>/<i>z</i> = 436.0 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-(Pyridin-3-ylmethyl){[4-(benzenesulfonyl)phenyl]amino}sulfonamide (<b>38</b>)</h3><div class="NLM_p last">To the solution of compound <b>64</b> (0.76 g, 1.814 mmol) in ACN (15 mL), pyridin-3-ylmethanamine (<b>51a</b>; 0.196 g, 1.814 mmol) and TEA (0.506 mL, 3.63 mmol) were added. The mixture was heated to 80 °C for 16 h. After removal of the solvent, the crude product was purified by Biotage using MeOH–CH<sub>2</sub>Cl<sub>2</sub> from 0% to 12% to give the desired product (0.10 g, 14%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.47 (s, 1H), 8.50–8.39 (m, 1H), 8.36–8.29 (m, 2H), 7.93–7.87 (m, 2H), 7.84–7.74 (m, 2H), 7.69–7.55 (m, 3H), 7.48–7.43 (m, 1H), 7.20–7.14 (m, 2H), 6.99–6.92 (m, 1H), 4.03 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.30 min, <i>m</i>/<i>z</i> = 404.0 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/jm400186h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of computational methods, details of analytical LCMS and LC/MS/MS methods, in vitro and in vivo ADME and experimental procedures, experimental details for PK and efficacy study of compound <b>50</b> in the mouse, protein expression/purification and crystallographic methods and procedures for <b>5</b> (in complex with Nampt), details of Nampt biochemical and cell-based assays. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400186h/suppl_file/jm400186h_si_001.pdf">jm400186h_si_001.pdf (552.89 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JR5">4JR5</a> for <b>5</b> complexed with Nampt.</p><div class="testing" data-doi="10.1021/jm400186h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaozhang Zheng</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#aad2d0c2cfc4cdeaccc5d8c7cbdec2cfd8cbdacfdfdec3c9d984c9c5c7"><span class="__cf_email__" data-cfemail="31494b59545f5671575e435c504559544350415444455852421f525e5c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bauer</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timm Baumeister</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre J. Buckmelter</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maureen Caligiuri</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl H. Clodfelter</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bingsong Han</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yen-Ching Ho</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolai Kley</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Lin</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominic J. Reynolds</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geeta Sharma</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chase C. Smith</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongguo Wang</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter S. Dragovich</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Oh</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiru Wang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Zak</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Gunzner-Toste</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiling Zhao</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Po-wai Yuen</span> - <span class="hlFld-Affiliation affiliation">Pharmaron Beijing, Co. Ltd., 6
Tai He Road, BDA Beijing, 100176, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth W. Bair</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics, Inc., 500
Arsenal Street, Watertown, Massachusetts 02472, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d55e4248-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Forma’s high speed synthesis group for their synthetic contributions and the ADME group for generating the microsomal and solubility data, Rashida Garcia-Dancey for helping generating the cellular data, Lakshmanan Manikandan, Saradhi Vijay, and Danilal C. Sharma for generating the in vivo PK and efficacy data, Agilent Technologies (Woburn, MA) for generating the Rapidfire LCMS data, Tandem Laboratories (Woburn, MA) for performing the phosphoribosylated adduct study, Professor Yigong Shi’s group (Tsinghua University, Beijing, China) for providing Nampt DNA construct and Nampt protein, and James Kyranos for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> Abbreviations Used</h2><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time to reach the maximum concentration</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume distribution</p></td></tr><tr><td class="NLM_term">Na<sub>2</sub>SO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium sulfite</p></td></tr><tr><td class="NLM_term">NaHCO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium bicarbonate</p></td></tr><tr><td class="NLM_term">Cu(OAc)<sub>2</sub></td><td class="NLM_def"><p class="first last">copper acetate</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">LiOH</td><td class="NLM_def"><p class="first last">lithium hydroxide</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">CH<sub>2</sub>Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">brine</td><td class="NLM_def"><p class="first last">a saturated aqueous solution of sodium chloride</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">SCX</td><td class="NLM_def"><p class="first last">strong cationic exchange</p></td></tr><tr><td class="NLM_term">NH<sub>4</sub>OH</td><td class="NLM_def"><p class="first last">ammonium hydroxide</p></td></tr><tr><td class="NLM_term">Na<sub>2</sub>SO<sub>4</sub></td><td class="NLM_def"><p class="first last">sodium sulfate</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">NH<sub>4</sub>HCO<sub>3</sub></td><td class="NLM_def"><p class="first last">ammonium bicarbonate</p></td></tr><tr><td class="NLM_term">NaCl</td><td class="NLM_def"><p class="first last">sodium chloride</p></td></tr><tr><td class="NLM_term">MgCl<sub>2</sub></td><td class="NLM_def"><p class="first last">magnesium chloride</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tris(hydroxypropyl)phosphine</p></td></tr><tr><td class="NLM_term">D5W</td><td class="NLM_def"><p class="first last">5% dextrose in water</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">50754</span><span class="NLM_x">–</span> <span class="NLM_lpage">50763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=50754-50763&author=J.+R.+Revolloauthor=A.+A.+Grimmauthor=S.+Imai&title=The+NAD+biosynthesis+pathway+mediated+by+nicotinamide+phosphoribosyltransferase+regulates+Sir2+activity+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DGrimm%26aufirst%3DA.%2BA.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DThe%2520NAD%2520biosynthesis%2520pathway%2520mediated%2520by%2520nicotinamide%2520phosphoribosyltransferase%2520regulates%2520Sir2%2520activity%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D50754%26epage%3D50763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rongvaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span> </span><span class="NLM_article-title">The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8-11&author=M.+Galliauthor=F.+Van+Goolauthor=A.+Rongvauxauthor=F.+Andrisauthor=O.+Leo&title=The+nicotinamide+phosphoribosyltransferase%3A+a+molecular+link+between+metabolism%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DRongvaux%26aufirst%3DA.%26aulast%3DAndris%26aufirst%3DF.%26aulast%3DLeo%26aufirst%3DO.%26atitle%3DThe%2520nicotinamide%2520phosphoribosyltransferase%253A%2520a%2520molecular%2520link%2520between%2520metabolism%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt: Linking NAD Biology, Metabolism and Cancer</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1016%2Fj.tem.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19109034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=130-138&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Kornerauthor=S.-I.+Imaiauthor=W.+Kiess&title=Nampt%3A+Linking+NAD+Biology%2C+Metabolism+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt: linking NAD biology, metabolism and cancer</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Koerner, Antje; Imai, Shin-ichiro; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to NMN, a key NAD intermediate.  Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biol., metab. and inflammation.  As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt also plays an important part in regulating insulin secretion in pancreatic β-cells.  Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation.  This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMtmRWd15knbVg90H21EOLACvtfcHk0lgY2yn3Ira3rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D&md5=2e6fc10db431e1963b0b827747466c53</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.-I.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%253A%2520Linking%2520NAD%2520Biology%252C%2520Metabolism%2520and%2520Cancer%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Belenky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">NAD<sup>+</sup> metabolism in health and disease</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=12-19&author=P.+Belenkyauthor=K.+L.+Boganauthor=C.+Brenner&title=NAD%2B+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelenky%26aufirst%3DP.%26aulast%3DBogan%26aufirst%3DK.%2BL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DNAD%252B%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2007%26volume%3D32%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zaremba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulthard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1038%2Fsj.bjc.6605166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19568233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=256-262&author=T.+Zarembaauthor=P.+Ketzerauthor=M.+Coleauthor=S.+Coulthardauthor=E.+R.+Plummerauthor=N.+J.+Curtin&title=Poly%28ADP-ribose%29+polymerase-1+polymorphisms%2C+expression+and+activity+in+selected+human+tumour+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span></div><div class="casAuthors">Zaremba, T.; Ketzer, P.; Cole, M.; Coulthard, S.; Plummer, E. R.; Curtin, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding enzyme activated by DNA breaks and involved in DNA repair and other cellular processes.  Poly(ADP-ribose) polymerase activity can be higher in cancer than in adjacent normal tissue, but cancer predisposition is reported to be greater in individuals with a single-nucleotide polymorphism (SNP) V762A (T2444C) in the catalytic domain that reduces PARP-1 activity.  Methods: To resolve these divergent observations, we detd. PARP-1 polymorphisms, PARP-1 protein expression and activity in a panel of 19 solid and haematol., adult and pediatric human cancer cell lines.  Results: There was a wide variation in PARP activity in the cell line panel (coeff. of variation, CV=103%), with the lowest and the highest activity being 2460 pmol PAR/106 (HS-5 cells) and 85 750 pmol PAR/106 (NGP cells).  Lower variation (CV=32%) was obsd. in PARP-1 protein expression with the lowest expression being 2.0 ng μg-1 (HS-5 cells) and the highest being 7.1 ng μg-1 (ML-1 cells).  The mean activity in the cancer cells was 45-fold higher than the mean activity in normal human lymphocytes and the PARP-1 protein levels were 23-fold higher.  Conclusions: Surprisingly, there was no significant correlation between PARP activity and PARP-1 protein level or the investigated polymorphisms, T2444C and CA.  British Journal of Cancer (2009) 101, 256-262; doi:10.1038/sj.bjc.6605166 www.bjcancer.com Published online 30 June 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiXp9dmBsH7Vg90H21EOLACvtfcHk0ljg0iC3Ky0Vmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D&md5=2e8cbeef3e92351d2afd5bed60ad77d4</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605166%26sid%3Dliteratum%253Aachs%26aulast%3DZaremba%26aufirst%3DT.%26aulast%3DKetzer%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DM.%26aulast%3DCoulthard%26aufirst%3DS.%26aulast%3DPlummer%26aufirst%3DE.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520polymorphisms%252C%2520expression%2520and%2520activity%2520in%2520selected%2520human%2520tumour%2520cell%2520lines%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouhar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1517%2F14728222.11.5.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=17465726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=695-705&author=J.+A.+Khanauthor=F.+Forouharauthor=X.+Taoauthor=L.+Tong&title=Nicotinamide+adenine+dinucleotide+metabolism+as+an+attractive+target+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span></div><div class="casAuthors">Khan, Javed A.; Forouhar, Farhad; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-705</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  NAD (NAD+) has crucial roles in many cellular processes, both as a coenzyme for redox reactions and as a substrate to donate ADP-ribose units.  Enzymes involved in NAD+ metab. are attractive targets for drug discovery against a variety of human diseases, including cancer, multiple sclerosis, neurodegeneration and Huntington's disease.  A small-mol. inhibitor of nicotinamide phosphoribosyltransferase, an enzyme in the salvage pathway of NAD+ biosynthesis, is presently in clin. trials against cancer.  An analog of a kynurenine pathway intermediate is efficacious against multiple sclerosis in an animal model.  Indoleamine 2,3-dioxygenase plays an important role in immune evasion by cancer cells and other disease processes.  Inhibitors against kynurenine 3-hydroxylase can reduce the prodn. of neurotoxic metabolites while increasing the prodn. of neuroprotective compds.  This review summarizes the existing knowledge on NAD+ metabolic enzymes, with emphasis on their relevance for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrpVwpXgPHrVg90H21EOLACvtfcHk0ljg0iC3Ky0Vmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D&md5=43a4c12a1a780feddd233e1d8209f3f6</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.5.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.5.695%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DForouhar%26aufirst%3DF.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DNicotinamide%2520adenine%2520dinucleotide%2520metabolism%2520as%2520an%2520attractive%2520target%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D695%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Koppenol, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounds, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Otto Warburg’s contributions to current concepts of cancer metabolism</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1038%2Fnrc3038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=21508971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=325-337&author=W.+H.+Koppenolauthor=P.+L.+Boundsauthor=C.+V.+Dang&title=Otto+Warburg%E2%80%99s+contributions+to+current+concepts+of+cancer+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Otto Warburg's contributions to current concepts of cancer metabolism</span></div><div class="casAuthors">Koppenol, Willem H.; Bounds, Patricia L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">325-337</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Otto Warburg pioneered quant. investigations of cancer cell metab., as well as photosynthesis and respiration.  Warburg and co-workers showed in the 1920s that, under aerobic conditions, tumor tissues metabolize approx. tenfold more glucose to lactate in a given time than normal tissues, a phenomenon known as the Warburg effect.  However, this increase in aerobic glycolysis in cancer cells is often erroneously thought to occur instead of mitochondrial respiration and has been misinterpreted as evidence for damage to respiration instead of damage to the regulation of glycolysis.  In fact, many cancers exhibit the Warburg effect while retaining mitochondrial respiration.  We re-examine Warburg's observations in relation to the current concepts of cancer metab. as being intimately linked to alterations of mitochondrial DNA, oncogenes and tumor suppressors, and thus readily exploitable for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdteDUarw-PbVg90H21EOLACvtfcHk0ljg0iC3Ky0Vmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D&md5=72988f428422daecd23b21d242aec18a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnrc3038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3038%26sid%3Dliteratum%253Aachs%26aulast%3DKoppenol%26aufirst%3DW.%2BH.%26aulast%3DBounds%26aufirst%3DP.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DOtto%2520Warburg%25E2%2580%2599s%2520contributions%2520to%2520current%2520concepts%2520of%2520cancer%2520metabolism%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D325%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Metabolic reprogramming: a cancer hallmark even warburg did not anticipate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1016%2Fj.ccr.2012.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=22439925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=297-308&author=P.+S.+Wardauthor=C.+B.+Thompson&title=Metabolic+reprogramming%3A+a+cancer+hallmark+even+warburg+did+not+anticipate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate</span></div><div class="casAuthors">Ward, Patrick S.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-308</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer metab. has long been equated with aerobic glycolysis, seen by early biochemists as primitive and inefficient.  Despite these early beliefs, the metabolic signatures of cancer cells are not passive responses to damaged mitochondria but result from oncogene-directed metabolic reprogramming required to support anabolic growth.  Recent evidence suggests that metabolites themselves can be oncogenic by altering cell signaling and blocking cellular differentiation.  No longer can cancer-assocd. alterations in metab. be viewed as an indirect response to cell proliferation and survival signals.  We contend that altered metab. has attained the status of a core hallmark of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFCvg4k-_m7Vg90H21EOLACvtfcHk0lguOKYUGnP60g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D&md5=8e991ba77d1bb0b57c3009b6bc39ee99</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DMetabolic%2520reprogramming%253A%2520a%2520cancer%2520hallmark%2520even%2520warburg%2520did%2520not%2520anticipate%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D297%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cerna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. S.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by the small molecule GMX1778 regulates ROS-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">22408</span><span class="NLM_x">–</span> <span class="NLM_lpage">22417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=22408-22417&author=D.+Cernaauthor=H.+Liauthor=S.+Flahertyauthor=N.+Takebeauthor=C.+N.+Colemanauthor=S.+S.+Yoo&title=Inhibition+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+activity+by+the+small+molecule+GMX1778+regulates+ROS-mediated+cytotoxicity+in+a+p53-+and+nicotinic+acid+phosphoribosyltransferase1+%28NAPRT1%29-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerna%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DFlaherty%26aufirst%3DS.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DColeman%26aufirst%3DC.%2BN.%26aulast%3DYoo%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520activity%2520by%2520the%2520small%2520molecule%2520GMX1778%2520regulates%2520ROS-mediated%2520cytotoxicity%2520in%2520a%2520p53-%2520and%2520nicotinic%2520acid%2520phosphoribosyltransferase1%2520%2528NAPRT1%2529-dependent%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D22408%26epage%3D22417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0lguOKYUGnP60g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Biedermann, E.; Hasmann, M.; Loser, R.; Rattel, B.; Reiter, F.; Schein, B.; Seibel, K.; Vogt, K.</span><span> </span><span class="NLM_article-title">Preparation and formulation of pyridine derivatives as antitumor agents and immunosuppressants</span>. WO 9748397,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=E.+Biedermann&author=M.+Hasmann&author=R.+Loser&author=B.+Rattel&author=F.+Reiter&author=B.+Schein&author=K.+Seibel&author=K.+Vogt&title=Preparation+and+formulation+of+pyridine+derivatives+as+antitumor+agents+and+immunosuppressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiedermann%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520formulation%2520of%2520pyridine%2520derivatives%2520as%2520antitumor%2520agents%2520and%2520immunosuppressants%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauske, A.-R.</span><span> </span><span class="NLM_article-title">The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=45-51&author=K.+Holenauthor=L.+B.+Saltzauthor=E.+Hollywoodauthor=K.+Burkauthor=A.-R.+Hanauske&title=The+pharmacokinetics%2C+toxicities%2C+and+biologic+effects+of+FK866%2C+a+nicotinamide+adenine+dinucleotide+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DHollywood%26aufirst%3DE.%26aulast%3DBurk%26aufirst%3DK.%26aulast%3DHanauske%26aufirst%3DA.-R.%26atitle%3DThe%2520pharmacokinetics%252C%2520toxicities%252C%2520and%2520biologic%2520effects%2520of%2520FK866%252C%2520a%2520nicotinamide%2520adenine%2520dinucleotide%2520biosynthesis%2520inhibitor%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottosen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">Novel cyanoguanidines with potent oral antitumor activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3095-3100&author=C.+Schouauthor=E.+R.+Ottosenauthor=H.+J.+Petersenauthor=F.+Bjorklingauthor=S.+Latiniauthor=P.+V.+Hjarnaaauthor=E.+Brammauthor=L.+Binderup&title=Novel+cyanoguanidines+with+potent+oral+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchou%26aufirst%3DC.%26aulast%3DOttosen%26aufirst%3DE.%2BR.%26aulast%3DPetersen%26aufirst%3DH.%2BJ.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DNovel%2520cyanoguanidines%2520with%2520potent%2520oral%2520antitumor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3095%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ravaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3weeks in solid tumours: An ECSG/EORTC study</span> <span class="citation_source-journal">Eur. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=702-707&author=A.+Ravaudauthor=T.+Cernyauthor=C.+Terretauthor=J.+Wandersauthor=B.+N.+Buiauthor=D.+Hessauthor=J.-P.+Drozauthor=P.+Fumoleauauthor=C.+Twelves&title=Phase+I+study+and+pharmacokinetic+of+CHS-828%2C+a+guanidino-containing+compound%2C+administered+orally+as+a+single+dose+every+3weeks+in+solid+tumours%3A+An+ECSG%2FEORTC+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavaud%26aufirst%3DA.%26aulast%3DCerny%26aufirst%3DT.%26aulast%3DTerret%26aufirst%3DC.%26aulast%3DWanders%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DB.%2BN.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DDroz%26aufirst%3DJ.-P.%26aulast%3DFumoleau%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520study%2520and%2520pharmacokinetic%2520of%2520CHS-828%252C%2520a%2520guanidino-containing%2520compound%252C%2520administered%2520orally%2520as%2520a%2520single%2520dose%2520every%25203weeks%2520in%2520solid%2520tumours%253A%2520An%2520ECSG%252FEORTC%2520study%26jtitle%3DEur.%2520J.%2520Cancer.%26date%3D2005%26volume%3D41%26spage%3D702%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hovstadium, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissmeyer, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasilnikoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonnebo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, J.</span><span> </span><span class="NLM_article-title">A phase I study of CHS 828 in patients with solid tumor malignancy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=12231525" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2843-2850&author=P.+Hovstadiumauthor=R.+Larssonauthor=E.+Jonssonauthor=T.+Skovauthor=A.-M.+Kissmeyerauthor=K.+Krasilnikoffauthor=J.+Berghauthor=M.+O.+Karlssonauthor=A.+Lonneboauthor=J.+Ahlgren&title=A+phase+I+study+of+CHS+828+in+patients+with+solid+tumor+malignancy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHovstadium%26aufirst%3DP.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DKissmeyer%26aufirst%3DA.-M.%26aulast%3DKrasilnikoff%26aufirst%3DK.%26aulast%3DBergh%26aufirst%3DJ.%26aulast%3DKarlsson%26aufirst%3DM.%2BO.%26aulast%3DLonnebo%26aufirst%3DA.%26aulast%3DAhlgren%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520CHS%2520828%2520in%2520patients%2520with%2520solid%2520tumor%2520malignancy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D2843%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasi Roman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=771-779&author=U.+Galliauthor=E.+Ercolanoauthor=L.+Carraroauthor=C.+R.+Blasi+Romanauthor=G.+Sorbaauthor=P.+L.+Canonicoauthor=A.+A.+Genazzaniauthor=G.+C.+Tronauthor=R.+A.+Billington&title=Synthesis+and+biological+evaluation+of+isosteric+analogues+of+FK866%2C+an+inhibitor+of+NAD+salvage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DErcolano%26aufirst%3DE.%26aulast%3DCarraro%26aufirst%3DL.%26aulast%3DBlasi%2BRoman%26aufirst%3DC.%2BR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DBillington%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520isosteric%2520analogues%2520of%2520FK866%252C%2520an%2520inhibitor%2520of%2520NAD%2520salvage%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D771%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Willardsen, A. J.; Lockman, J. W.; Murphy, B. R.; Judd, W. R.; Kim, I. C.; Kim, S.-H.; Zigar, D. F.; Yager, K. M.; Fleischer, T. C.; Terry-Lorenzo, R. T.; Boniface, J. J.; Parker, D. P.; McAlexander, I. A.; Bursavich, M. G.; Dastrup, D. M.</span><span> </span><span class="NLM_article-title">Compounds and therapeutic uses thereof</span>. WO 2011109441,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+J.+Willardsen&author=J.+W.+Lockman&author=B.+R.+Murphy&author=W.+R.+Judd&author=I.+C.+Kim&author=S.-H.+Kim&author=D.+F.+Zigar&author=K.+M.+Yager&author=T.+C.+Fleischer&author=R.+T.+Terry-Lorenzo&author=J.+J.+Boniface&author=D.+P.+Parker&author=I.+A.+McAlexander&author=M.+G.+Bursavich&author=D.+M.+Dastrup&title=Compounds+and+therapeutic+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWillardsen%26aufirst%3DA.%2BJ.%26atitle%3DCompounds%2520and%2520therapeutic%2520uses%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lockman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zigar, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattum, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry-Lorenzo, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischer, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span> </span><span class="NLM_article-title">Analogues of 4-[(7-bromo-2-methyl-4-oxo-3<i>H</i>-quinazolin-6-yl)methylprop-2-ynylamino]-<i>N</i>-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8734</span><span class="NLM_x">–</span> <span class="NLM_lpage">8746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101145b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8734-8746&author=J.+W.+Lockmanauthor=B.+R.+Murphyauthor=D.+F.+Zigarauthor=W.+R.+Juddauthor=P.+M.+Slattumauthor=Z.-H.+Gaoauthor=K.+Ostaninauthor=J.+Greenauthor=R.+McKinnonauthor=R.+T.+Terry-Lorenzoauthor=T.+C.+Fleischerauthor=J.+J.+Bonifaceauthor=M.+Shenderovichauthor=J.+A.+Willardsen&title=Analogues+of+4-%5B%287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%29methylprop-2-ynylamino%5D-N-%283-pyridylmethyl%29benzamide+%28CB-30865%29+as+potent+inhibitors+of+nicotinamide+phosphoribosyltransferase+%28Nampt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm101145b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101145b%26sid%3Dliteratum%253Aachs%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DMurphy%26aufirst%3DB.%2BR.%26aulast%3DZigar%26aufirst%3DD.%2BF.%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DGao%26aufirst%3DZ.-H.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DTerry-Lorenzo%26aufirst%3DR.%2BT.%26aulast%3DFleischer%26aufirst%3DT.%2BC.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DAnalogues%2520of%25204-%255B%25287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%2529methylprop-2-ynylamino%255D-N-%25283-pyridylmethyl%2529benzamide%2520%2528CB-30865%2529%2520as%2520potent%2520inhibitors%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8734%26epage%3D8746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kumar, D. V.; Slattum, P. M.; Yager, K. M.; Shenderovich, M. D.; Tangallapally, R.; Kim, S.</span><span> </span><span class="NLM_article-title">Compounds and therapeutic uses thereof</span>. WO 2012177782,<span class="NLM_x"> </span><span class="NLM_year">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+V.+Kumar&author=P.+M.+Slattum&author=K.+M.+Yager&author=M.+D.+Shenderovich&author=R.+Tangallapally&author=S.+Kim&title=Compounds+and+therapeutic+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DD.%2BV.%26atitle%3DCompounds%2520and%2520therapeutic%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Jegham, S.; Arigon, J.; Combet, R.; Hilairet, S.; Fraisse, P.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic use thereof</span>. US 20100222319,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=S.+Jegham&author=J.+Arigon&author=R.+Combet&author=S.+Hilairet&author=P.+Fraisse&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Duclos, O.; Bernhart, J. M.; Jegham, S.; McCort, G.</span><span> </span><span class="NLM_article-title">Antineoplastic derivatives, preparation thereof, and therapeutic use thereof</span>. WO 2010004198,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=O.+Duclos&author=J.+M.+Bernhart&author=S.+Jegham&author=G.+McCort&title=Antineoplastic+derivatives%2C+preparation+thereof%2C+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DAntineoplastic%2520derivatives%252C%2520preparation%2520thereof%252C%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bouaboula, M.; Combet, R.; Jegham, S.; Hilairet, S.</span><span> </span><span class="NLM_article-title">Anticancer compounds, preparation thereof, and therapeutic use thereof</span>. WO 2010109115,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Arigon&author=C.+Bernhart&author=M.+Bouaboula&author=R.+Combet&author=S.+Jegham&author=S.+Hilairet&title=Anticancer+compounds%2C+preparation+thereof%2C+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DAnticancer%2520compounds%252C%2520preparation%2520thereof%252C%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bouaboula, M.; Combet, R.; Hilairet, S.; Jegham, S.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic use thereof as anticancer drugs</span>. WO 2010109112,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Arigon&author=C.+Bernhart&author=M.+Bouaboula&author=R.+Combet&author=S.+Hilairet&author=S.+Jegham&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%2520as%2520anticancer%2520drugs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bouaboula, M.; Dimalta, A.; Nardi, F.; Jegham, S.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic uses thereof</span>. WO 2012038904,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Arigon&author=C.+Bernhart&author=M.+Bouaboula&author=A.+Dimalta&author=F.+Nardi&author=S.+Jegham&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bosch, M.; Bouaboula, M.; Nardi, F.; Jegham, S.; Combet, R.</span><span> </span><span class="NLM_article-title">Thienopyridine nicotinamide derivatives, preparation thereof and therapeutic use thereof</span>. WO 2012038905,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Arigon&author=C.+Bernhart&author=M.+Bosch&author=M.+Bouaboula&author=F.+Nardi&author=S.+Jegham&author=R.+Combet&title=Thienopyridine+nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DThienopyridine%2520nicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Curtin, M. L.; Sorensen, B. K.; Heyman, H. R.; Clark, R. F.; Woller, K. R.; Shah, O. J.; Michaelides, Mi.; Tse, C.; Vasudevan, A.; Mack, H.; Hansen, T. M.; Sweis, R.; Pliushchev, M. A.</span><span> </span><span class="NLM_article-title">Dihydroisoindolecarboxamide derivatives as NAMPT and ROCK inhibitors and their preparation</span>. US 20120122842,<span class="NLM_x"> </span><span class="NLM_year">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+L.+Curtin&author=B.+K.+Sorensen&author=H.+R.+Heyman&author=R.+F.+Clark&author=K.+R.+Woller&author=O.+J.+Shah&author=Mi.+Michaelides&author=C.+Tse&author=A.+Vasudevan&author=H.+Mack&author=T.+M.+Hansen&author=R.+Sweis&author=M.+A.+Pliushchev&title=Dihydroisoindolecarboxamide+derivatives+as+NAMPT+and+ROCK+inhibitors+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26atitle%3DDihydroisoindolecarboxamide%2520derivatives%2520as%2520NAMPT%2520and%2520ROCK%2520inhibitors%2520and%2520their%2520preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Curtin, M. L.; Sorensen, B. K.; Heyman, H. R.; Clark, R. F.; Michaelides, M.; Tse, C.</span><span> </span><span class="NLM_article-title">NAMPT inhibitors as therapeutic agents for the treatment of diseases</span>US 20120122924,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+L.+Curtin&author=B.+K.+Sorensen&author=H.+R.+Heyman&author=R.+F.+Clark&author=M.+Michaelides&author=C.+Tse&title=NAMPT+inhibitors+as+therapeutic+agents+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26atitle%3DNAMPT%2520inhibitors%2520as%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">13748</span><span class="NLM_x">–</span> <span class="NLM_lpage">13753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=13748-13753&author=E.+S.+Burgosauthor=M.-C.+Hoauthor=S.+C.+Almoauthor=V.+L.+Schramm&title=A+phosphoenzyme+mimic%2C+overlapping+catalytic+sites+and+reaction+coordinate+motion+for+human+NAMPT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DHo%26aufirst%3DM.-C.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DA%2520phosphoenzyme%2520mimic%252C%2520overlapping%2520catalytic%2520sites%2520and%2520reaction%2520coordinate%2520motion%2520for%2520human%2520NAMPT%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D13748%26epage%3D13753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vajda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarnieri, F.</span><span> </span><span class="NLM_article-title">Characterization of protein–ligand interaction sites using experimental and computational methods</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=363-369&author=S.+Vajdaauthor=F.+Guarnieri&title=Characterization+of+protein%E2%80%93ligand+interaction+sites+using+experimental+and+computational+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVajda%26aufirst%3DS.%26aulast%3DGuarnieri%26aufirst%3DF.%26atitle%3DCharacterization%2520of%2520protein%25E2%2580%2593ligand%2520interaction%2520sites%2520using%2520experimental%2520and%2520computational%2520methods%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">CS-Map distributes solvent like probe molecules over the protein surface, minimizes their energy independently, clusters the resulting probe positions, and ranks the clusters thereby identifying sites where probes consistently bind.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CS-Map+distributes+solvent+like+probe+molecules+over+the+protein+surface%2C+minimizes+their+energy+independently%2C+clusters+the+resulting+probe+positions%2C+and+ranks+the+clusters+thereby+identifying+sites+where+probes+consistently+bind."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Landon, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancia, D. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajda, S.</span><span> </span><span class="NLM_article-title">Identification of hot spots within druggable binding regions by computational solvent mapping of proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061134b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1231-1240&author=M.+R.+Landonauthor=D.+R.+Lanciaauthor=J.+Yuauthor=S.+C.+Thielauthor=S.+Vajda&title=Identification+of+hot+spots+within+druggable+binding+regions+by+computational+solvent+mapping+of+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Hot Spots within Druggable Binding Regions by Computational Solvent Mapping of Proteins</span></div><div class="casAuthors">Landon, Melissa R.; Lancia, David R., Jr.; Yu, Jessamin; Thiel, Spencer C.; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1231-1240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here the authors apply the computational solvent mapping (CS-Map) algorithm toward the in silico identification of hot spots, i.e., regions of protein binding sites that are major contributors to the binding energy and, hence, are prime targets in drug design.  The CS-Map algorithm, developed for binding site characterization, moves small org. functional groups around the protein surface and dets. their most energetically favorable binding positions.  The utility of CS-Map algorithm toward the prediction of hot spot regions in druggable binding pockets is illustrated by three test systems: (1) renin aspartic protease, (2) a set of previously characterized druggable proteins, and (3) E. coli ketopantoate reductase.  In each of the three studies, existing literature was used to verify the results.  Based on the authors analyses, the authors conclude that the information provided by CS-Map can contribute substantially to the identification of hot spots, a necessary predecessor of fragment-based drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVim9shdtBbVg90H21EOLACvtfcHk0lgbeJDWJFDfAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWisrw%253D&md5=2d6a0678acdb2dd45fed73b05229bd03</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm061134b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061134b%26sid%3Dliteratum%253Aachs%26aulast%3DLandon%26aufirst%3DM.%2BR.%26aulast%3DLancia%26aufirst%3DD.%2BR.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DThiel%26aufirst%3DS.%2BC.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520hot%2520spots%2520within%2520druggable%2520binding%2520regions%2520by%2520computational%2520solvent%2520mapping%2520of%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1231%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span> <span class="citation_source-journal">Nature Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1038%2Fnsmb1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=16783377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=582-588&author=J.+A.+Khanauthor=X.+Taoauthor=L.+Tong&title=Molecular+basis+for+the+inhibition+of+human+NMPRTase%2C+a+novel+target+for+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span></div><div class="casAuthors">Khan, Javed A.; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors.  The authors have detd. the crystal structures at up to 2.1-Å resoln. of human and murine NMPRTase, alone and in complex with the reaction product NMN or the inhibitor FK866.  The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies.  FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866.  Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate.  Our structural and biochem. studies provide a starting point for the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s-XY1uB70LVg90H21EOLACvtfcHk0lgbeJDWJFDfAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D&md5=debef567dbcf629422472ef1b63dc396</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1105%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520inhibition%2520of%2520human%2520NMPRTase%252C%2520a%2520novel%2520target%2520for%2520anticancer%2520agents%26jtitle%3DNature%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D582%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span> </span><span class="NLM_article-title">Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1093%2Fjb%2Fmvp152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19819904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1KgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2010&pages=95-107&author=R.+Takahashiauthor=S.+Nakamuraauthor=T.+Nakazawaauthor=K.+Minouraauthor=T.+Yoshidaauthor=Y.+Nishiauthor=Y.+Kobayashiauthor=T.+Ohkubo&title=Structure+and+reaction+mechanism+of+human+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase</span></div><div class="casAuthors">Takahashi, Ryo; Nakamura, Shota; Nakazawa, Takashi; Minoura, Katsuhiko; Yoshida, Takuya; Nishi, Yoshinori; Kobayashi, Yuji; Ohkubo, Tadayasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-107</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Nicotinamide (NM) phosphoribosyltransferase (NMPRTase) catalyzes the reaction of NM and 5'-phosphoribosyl-1'-pyrophosphate (PRPP) to form NMN (NMN) and pyrophosphate (PPi) in the pathway of NAD biosynthesis.  Monitoring the 1H and 31P NMR spectra of the reaction mixt., it was found that this reaction was reversible as dictated by the equil. const., K = [NMN][PPi]/([NM][PRPP]) = 0.14, which agreed well with the ratio of 2nd-order rate consts. for the forward and backward reactions, K = 0.16.  The crystal structures of this enzyme in the free form and bound to NM and PRPP at a resoln. of 2.0-2.2 Å were essentially identical to that of the complex with NMN, except for some variations that could facilitate the substitution reaction by fixing the nucleophile and the leaving group for the requisite inversion of configuration at the C1' carbon of the ribose ring.  In the active site near the C1' atom of the bound PRPP or NMN, there was neither neg. charged group nor waterproof environment necessary to support the feasibility of a ribo-oxocarbocation intermediate inherent in the SN1 mechanism.  The structures and catalytic mechanism thus revealed were also discussed in connection with the multiple biol. functions of NMPRTase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoryShxAcZioLVg90H21EOLACvtfcHk0lhVZKrwP5cSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1KgtA%253D%253D&md5=a0e2dd70ae69bce884a1d1a8fcfb4b4e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvp152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvp152%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DNakazawa%26aufirst%3DT.%26aulast%3DMinoura%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DNishi%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DOhkubo%26aufirst%3DT.%26atitle%3DStructure%2520and%2520reaction%2520mechanism%2520of%2520human%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D147%26spage%3D95%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span>EMolecules Plus screening compound library. <a href="http://www.emolecules.com" class="extLink">http://www.emolecules.com</a>. (Accessed May<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EMolecules+Plus+screening+compound+library.+http%3A%2F%2Fwww.emolecules.com.+%28Accessed+May+2010%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lhVZKrwP5cSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lhVZKrwP5cSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD<sup>+</sup> biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">–</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Berger&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0lhGE0c2l5AmtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Because of the tight binding of these inhibitors and significant substrate inhibition caused by high NAM concentrations, the competitive inhibition data are presented in the manner shown as opposed to more traditional Michaelis–Menten type methods (i.e., 1/<i>V</i> vs 1/Substrate plots). See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for additional details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1002%2F0471220639" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+A.+Copeland&title=Enzymes%3A+A+Practical+Introduction+to+Structure%2C+Mechanism%2C+and+Data+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F0471220639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEnzymes%253A%2520A%2520Practical%2520Introduction%2520to%2520Structure%252C%2520Mechanism%252C%2520and%2520Data%2520Analysis%26pub%3DWiley-VCH%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">The media employed for the cell culture experiments contained 8 μM NAM. Intracellular NAM concentrations were not measured in these experiments.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">The ability of NAM to attenuate the cell potency of Nampt inhibitors has been previously described in the literature:</p></div><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span> </span><span class="NLM_article-title">FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7436</span><span class="NLM_x">–</span> <span class="NLM_lpage">7442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=14612543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7436-7442&author=M.+Hasmannauthor=I.+Schemainda&title=FK866%2C+a+highly+specific+noncompetitive+inhibitor+of+nicotinamide+phosphoribosyltransferase%2C+represents+a+novel+mechanism+for+induction+of+tumor+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis</span></div><div class="casAuthors">Hasmann, Max; Schemainda, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7436-7442</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulation of apoptosis, the physiol. form of cell death, is closely assocd. with immunol. diseases and cancer.  Apoptosis is activated either by death receptor-driven or mitochondrial pathways, both of which may provide potential targets for novel anticancer drugs.  Although several ligands stimulating death receptors have been described, the actual mol. events triggering the mitochondrial pathway are largely unknown.  Here, we show initiation of apoptosis by gradual depletion of the intracellular coenzyme NAD+.  We identified the first low mol. wt. compd., designated FK866, which induces apoptosis by highly specific, noncompetitive inhibition of nicotinamide phosphoribosyltransferase (NAPRT), a key enzyme in the regulation of NAD+ biosynthesis from the natural precursor nicotinamide.  Interference with this enzyme does not primarily intoxicate cells because the mitochondrial respiratory activity and the NAD+-dependent redox reactions involved remain unaffected as long as NAD+ is not effectively depleted by catabolic reactions.  Certain tissues, however, have a high turnover of NAD+ through its cleavage by enzymes like poly(ADP-ribose) polymerase.  Such cells often rely on the more readily available nicotinamide pathway for NAD+ synthesis and undergo apoptosis after inhibition of NAPRT, whereas cells effectively using the nicotinic acid pathway for NAD+ synthesis remain unaffected.  In support of this concept, FK866 effectively induced delayed cell death by apoptosis in HepG2 human liver carcinoma cells with an IC50 of ∼1 nM, did not directly inhibit mitochondrial respiratory activity, but caused gradual NAD+ depletion through specific inhibition of NAPRT.  This enzyme, when partially purified from K562 human leukemia cells, was noncompetitively inhibited by FK866, and the inhibitor consts. were calcd. to be 0.4 nM for the enzyme/substrate complex (Ki) and 0.3 nM for the free enzyme (Ki'), resp.  Nicotinic acid and nicotinamide were both found to have antidote potential for the cellular effects of FK866.  FK866 may be used for treatment of diseases implicating deregulated apoptosis such as cancer for immunosuppression or as a sensitizer for genotoxic agents.  Furthermore, it may provide an important tool for investigation of the mol. triggers of the mitochondrial pathway leading to apoptosis through enabling temporal sepn. of NAD+ decrease from ATP breakdown and apoptosis by several days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAOS3LOADp6LVg90H21EOLACvtfcHk0lhGE0c2l5AmtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D&md5=c67fd08fdfc233ba86478967b13d19a2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DSchemainda%26aufirst%3DI.%26atitle%3DFK866%252C%2520a%2520highly%2520specific%2520noncompetitive%2520inhibitor%2520of%2520nicotinamide%2520phosphoribosyltransferase%252C%2520represents%2520a%2520novel%2520mechanism%2520for%2520induction%2520of%2520tumor%2520cell%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7436%26epage%3D7442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The phenomenon of potent Nampt enzyme inhibition affording relatively weak cellular activity was also observed by others with a different inhibitor series (reference <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">8b</a>). The authors of this study noted that 95–96% inhibition of Nampt was required to afford good cell potency. It is likely that these observations are related to those described in the present work. Additional experiments will be required to better understand the relationships between Nampt enzyme inhibition and corresponding cellular activity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e','cit10f'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':[],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ryan T. Howard, Paul Hemsley, Philip Petteruti, Charlie N. Saunders, Javier A. Molina Bermejo, James S. Scott, Jeffrey W. Johannes, <span class="NLM_string-name hlFld-ContribAuthor">Edward W. Tate</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , 325-333. <a href="https://doi.org/10.1021/acschembio.9b00963" title="DOI URL">https://doi.org/10.1021/acschembio.9b00963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00963%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructure-Guided%252BDesign%252Band%252BIn-Cell%252BTarget%252BProfiling%252Bof%252Ba%252BCell-Active%252BTarget%252BEngagement%252BProbe%252Bfor%252BPARP%252BInhibitors%26aulast%3DHoward%26aufirst%3DRyan%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D04022020%26date%3D10022020%26date%3D04022020%26volume%3D15%26issue%3D2%26spage%3D325%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Xinglin  Yang</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 7965-7983. <a href="https://doi.org/10.1021/acs.jmedchem.7b00467" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00467%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BInhibitors%252BSimultaneously%252BTargeting%252BCancer%252BMetabolism%252Band%252BEpigenetics%25253A%252BDiscovery%252Bof%252BNovel%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual%252BInhibitors%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27032017%26date%3D21092017%26date%3D12102017%26date%3D08092017%26volume%3D60%26issue%3D19%26spage%3D7965%26epage%3D7983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span> and <span class="hlFld-ContribAuthor ">Demetri T.  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3552-3579. <a href="https://doi.org/10.1021/acs.jmedchem.6b01807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BNecessary%252BNitrogen%252BAtom%25253A%252BA%252BVersatile%252BHigh-Impact%252BDesign%252BElement%252Bfor%252BMultiparameter%252BOptimization%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D09122016%26date%3D08022017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Snahel  Patel</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Jasleen  Sodhi</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, and <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8345-8368. <a href="https://doi.org/10.1021/acs.jmedchem.6b00697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMinimizing%252BCYP2C9%252BInhibition%252Bof%252BExposed-Pyridine%252BNAMPT%252B%252528Nicotinamide%252BPhosphoribosyltransferase%252529%252BInhibitors%26aulast%3DZak%26aufirst%3DMark%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06052016%26date%3D30082016%26date%3D22092016%26date%3D19082016%26volume%3D59%26issue%3D18%26spage%3D8345%26epage%3D8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhong  Bai</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Yanghan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaochu  Qin</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yatao  Qiu</span>, <span class="hlFld-ContribAuthor ">Dongguang  Qin</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, and <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5766-5779. <a href="https://doi.org/10.1021/acs.jmedchem.6b00324" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00324%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BPotent%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%252Bwith%252BPromising%252Bin%252BVitro%252Band%252Bin%252BVivo%252BAntitumor%252BActivities%26aulast%3DBai%26aufirst%3DJinhong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29022016%26date%3D13062016%26date%3D23062016%26date%3D25052016%26volume%3D59%26issue%3D12%26spage%3D5766%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Brandon J.  Bravo</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Yezhen  Feng</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Youming  Shen</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, and <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 770-792. <a href="https://doi.org/10.1021/jm4015108" title="DOI URL">https://doi.org/10.1021/jm4015108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4015108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4015108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BIdentification%252Bof%252BAmides%252BDerived%252Bfrom%252Btrans-2-%252528Pyridin-3-yl%252529cyclopropanecarboxylic%252BAcid%252Bas%252BPotent%252BInhibitors%252Bof%252BHuman%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DGiannetti%26aufirst%3DAnthony%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27092013%26date%3D22012014%26date%3D13022014%26date%3D09012014%26volume%3D57%26issue%3D3%26spage%3D770%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>, <span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Alberto  Massarotti</span>, <span class="hlFld-ContribAuthor ">Gohar  Fakhfouri</span>, <span class="hlFld-ContribAuthor ">Reza  Rahimian</span>, <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>, and <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>  . </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (16)
                                     , 6279-6296. <a href="https://doi.org/10.1021/jm4001049" title="DOI URL">https://doi.org/10.1021/jm4001049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4001049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4001049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252Bof%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252BInhibitors%26aulast%3DGalli%26aufirst%3DUbaldina%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22012013%26date%3D31052013%26date%3D22082013%26date%3D16052013%26volume%3D56%26issue%3D16%26spage%3D6279%26epage%3D6296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Paul  Bauer</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, and <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (16)
                                     , 6413-6433. <a href="https://doi.org/10.1021/jm4008664" title="DOI URL">https://doi.org/10.1021/jm4008664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4008664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4008664%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BNovel%252BAmide-Containing%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528Nampt%252529%252BInhibitors%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28042013%26date%3D31072013%26date%3D22082013%26date%3D16072013%26volume%3D56%26issue%3D16%26spage%3D6413%26epage%3D6433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony B.  Pinkerton</span>, <span class="hlFld-ContribAuthor ">E.  Hampton Sessions</span>, <span class="hlFld-ContribAuthor ">Paul  Hershberger</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Maloney</span>, <span class="hlFld-ContribAuthor ">Satyamaheshwar  Peddibhotla</span>, <span class="hlFld-ContribAuthor ">Meghan  Hopf</span>, <span class="hlFld-ContribAuthor ">Eduard  Sergienko</span>, <span class="hlFld-ContribAuthor ">Chen-Ting  Ma</span>, <span class="hlFld-ContribAuthor ">Layton H.  Smith</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jackson</span>, <span class="hlFld-ContribAuthor ">Jun  Tanaka</span>, <span class="hlFld-ContribAuthor ">Takashi  Tsuji</span>, <span class="hlFld-ContribAuthor ">Mayuko  Akiu</span>, <span class="hlFld-ContribAuthor ">Steven E.  Cohen</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Gardell</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of a Urea-containing Series of Nicotinamide Phosphoribosyltransferase (NAMPT) Activators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em> </em>, 128007. <a href="https://doi.org/10.1016/j.bmcl.2021.128007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252Ba%252BUrea-containing%252BSeries%252Bof%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252BActivators%26aulast%3DPinkerton%26aufirst%3DAnthony%2BB.%26date%3D2021%26spage%3D128007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott  Rice</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Cox</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Marsden</span>, <span class="hlFld-ContribAuthor ">Adam  Nelson</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient unified synthesis of diverse bridged polycyclic scaffolds using a complexity-generating ‘stitching’ annulation approach. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (5)
                                     , 599-602. <a href="https://doi.org/10.1039/D0CC06975B" title="DOI URL">https://doi.org/10.1039/D0CC06975B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06975B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06975B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DEfficient%252Bunified%252Bsynthesis%252Bof%252Bdiverse%252Bbridged%252Bpolycyclic%252Bscaffolds%252Busing%252Ba%252Bcomplexity-generating%252B%2525E2%252580%252598stitching%2525E2%252580%252599%252Bannulation%252Bapproach%26aulast%3DRice%26aufirst%3DScott%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D5%26spage%3D599%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jangampalli Adi  Pradeepkiran</span>, <span class="hlFld-ContribAuthor ">S.B.  Sainath</span>, <span class="hlFld-ContribAuthor ">Praveen K.  Balne</span>, <span class="hlFld-ContribAuthor ">M.  Bhaskar</span>. </span><span class="cited-content_cbyCitation_article-title">Computational modeling and evaluation of best potential drug targets through comparative modeling. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 39-78. <a href="https://doi.org/10.1016/B978-0-323-85681-2.00001-X" title="DOI URL">https://doi.org/10.1016/B978-0-323-85681-2.00001-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-85681-2.00001-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-85681-2.00001-X%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252Bmodeling%252Band%252Bevaluation%252Bof%252Bbest%252Bpotential%252Bdrug%252Btargets%252Bthrough%252Bcomparative%252Bmodeling%26aulast%3DPradeepkiran%26aufirst%3DJangampalli%2BAdi%26date%3D2021%26spage%3D39%26epage%3D78%26pub%3DElsevier%26atitle%3DBrucella%252BMelitensis%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua P.  Smalley</span>, <span class="hlFld-ContribAuthor ">Shaun M.  Cowley</span>, <span class="hlFld-ContribAuthor ">James T.  Hodgkinson</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional HDAC Therapeutics: One Drug to Rule Them All?. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (19)
                                     , 4394. <a href="https://doi.org/10.3390/molecules25194394" title="DOI URL">https://doi.org/10.3390/molecules25194394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25194394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25194394%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBifunctional%252BHDAC%252BTherapeutics%25253A%252BOne%252BDrug%252Bto%252BRule%252BThem%252BAll%25253F%26aulast%3DSmalley%26aufirst%3DJoshua%2BP.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D19%26spage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>, <span class="hlFld-ContribAuthor ">Kiyotaka  Katsuragi</span>, <span class="hlFld-ContribAuthor ">Takahiro  Oyama</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Yuri  Shibasaki</span>, <span class="hlFld-ContribAuthor ">Yasunobu  Asawa</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Kosho  Makino</span>, <span class="hlFld-ContribAuthor ">Miwa  Okazawa</span>, <span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Miyuki  Nomura</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Hideaki  Abe</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hideyo  Takahashi</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Tanuma</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3633. <a href="https://doi.org/10.3390/molecules25163633" title="DOI URL">https://doi.org/10.3390/molecules25163633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163633%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BBasis%252Bof%252BBeneficial%252BDesign%252Bfor%252BEffective%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%26aulast%3DTanuma%26aufirst%3DSei-ichi%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fikriye  Ozgencil</span>, <span class="hlFld-ContribAuthor ">Gokcen  Eren</span>, <span class="hlFld-ContribAuthor ">Yesim  Ozkan</span>, <span class="hlFld-ContribAuthor ">Sezen  Guntekin-Ergun</span>, <span class="hlFld-ContribAuthor ">Rengul  Cetin-Atalay</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115217. <a href="https://doi.org/10.1016/j.bmc.2019.115217" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115217%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bsmall-molecule%252Burea%252Bderivatives%252Bas%252Bnovel%252BNAMPT%252Binhibitors%252Bvia%252Bpharmacophore-based%252Bvirtual%252Bscreening%26aulast%3DOzgencil%26aufirst%3DFikriye%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen J.  Gardell</span>, <span class="hlFld-ContribAuthor ">Meghan  Hopf</span>, <span class="hlFld-ContribAuthor ">Asima  Khan</span>, <span class="hlFld-ContribAuthor ">Mauro  Dispagna</span>, <span class="hlFld-ContribAuthor ">E.  Hampton Sessions</span>, <span class="hlFld-ContribAuthor ">Rebecca  Falter</span>, <span class="hlFld-ContribAuthor ">Nidhi  Kapoor</span>, <span class="hlFld-ContribAuthor ">Jeanne  Brooks</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Culver</span>, <span class="hlFld-ContribAuthor ">Chris  Petucci</span>, <span class="hlFld-ContribAuthor ">Chen-Ting  Ma</span>, <span class="hlFld-ContribAuthor ">Steven E.  Cohen</span>, <span class="hlFld-ContribAuthor ">Jun  Tanaka</span>, <span class="hlFld-ContribAuthor ">Emmanuel S.  Burgos</span>, <span class="hlFld-ContribAuthor ">Jennifer S.  Hirschi</span>, <span class="hlFld-ContribAuthor ">Steven R.  Smith</span>, <span class="hlFld-ContribAuthor ">Eduard  Sergienko</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Pinkerton</span>. </span><span class="cited-content_cbyCitation_article-title">Boosting NAD+ with a small molecule that activates NAMPT. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-11078-z" title="DOI URL">https://doi.org/10.1038/s41467-019-11078-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-11078-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-11078-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DBoosting%252BNAD%25252B%252Bwith%252Ba%252Bsmall%252Bmolecule%252Bthat%252Bactivates%252BNAMPT%26aulast%3DGardell%26aufirst%3DStephen%2BJ.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saeb  Aliwaini</span>, <span class="hlFld-ContribAuthor ">Adel  Awadallah</span>, <span class="hlFld-ContribAuthor ">Rami  Morjan</span>, <span class="hlFld-ContribAuthor ">Mariam  Ghunaim</span>, <span class="hlFld-ContribAuthor ">Hala  Alqaddi</span>, <span class="hlFld-ContribAuthor ">Asmaa  Abuhamad</span>, <span class="hlFld-ContribAuthor ">Enas  Awadallah</span>, <span class="hlFld-ContribAuthor ">Yasmin  Abughefra</span>. </span><span class="cited-content_cbyCitation_article-title">Novel imidazo[1,2‑a]pyridine inhibits AKT/mTOR pathway and induces cell cycle arrest and apoptosis in melanoma and cervical cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2019.10341" title="DOI URL">https://doi.org/10.3892/ol.2019.10341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2019.10341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2019.10341%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DNovel%252Bimidazo%25255B1%25252C2%2525E2%252580%252591a%25255Dpyridine%252Binhibits%252BAKT%25252FmTOR%252Bpathway%252Band%252Binduces%252Bcell%252Bcycle%252Barrest%252Band%252Bapoptosis%252Bin%252Bmelanoma%252Band%252Bcervical%252Bcancer%252Bcells%26aulast%3DAliwaini%26aufirst%3DSaeb%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Bloomingdale</span>, <span class="hlFld-ContribAuthor ">Donald E.  Mager</span>. </span><span class="cited-content_cbyCitation_article-title">Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral Neuropathy. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2019,</strong> <em>36 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s11095-018-2562-7" title="DOI URL">https://doi.org/10.1007/s11095-018-2562-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-018-2562-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-018-2562-7%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DMachine%252BLearning%252BModels%252Bfor%252Bthe%252BPrediction%252Bof%252BChemotherapy-Induced%252BPeripheral%252BNeuropathy%26aulast%3DBloomingdale%26aufirst%3DPeter%26date%3D2019%26date%3D2019%26volume%3D36%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Kesherwani</span>, <span class="hlFld-ContribAuthor ">Sriram  Raghavan</span>, <span class="hlFld-ContribAuthor ">Krishnasamy  Gunasekaran</span>, <span class="hlFld-ContribAuthor ">Devadasan  Velmurugan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitors using computational approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (5)
                                     , 1306-1328. <a href="https://doi.org/10.1080/07391102.2017.1322004" title="DOI URL">https://doi.org/10.1080/07391102.2017.1322004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1322004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1322004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252Bnovel%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Busing%252Bcomputational%252Bapproaches%26aulast%3DKesherwani%26aufirst%3DManish%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D5%26spage%3D1306%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel S.  Palacios</span>, <span class="hlFld-ContribAuthor ">Erik  Meredith</span>, <span class="hlFld-ContribAuthor ">Toshio  Kawanami</span>, <span class="hlFld-ContribAuthor ">Christopher  Adams</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Veronique  Darsigny</span>, <span class="hlFld-ContribAuthor ">Erin  Geno</span>, <span class="hlFld-ContribAuthor ">Mark  Palermo</span>, <span class="hlFld-ContribAuthor ">Daniel  Baird</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Boynton</span>, <span class="hlFld-ContribAuthor ">Scott A.  Busby</span>, <span class="hlFld-ContribAuthor ">Elizabeth L.  George</span>, <span class="hlFld-ContribAuthor ">Chantale  Guy</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hewett</span>, <span class="hlFld-ContribAuthor ">Laryssa  Tierney</span>, <span class="hlFld-ContribAuthor ">Sachin  Thigale</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Weihofen</span>, <span class="hlFld-ContribAuthor ">Louis  Wang</span>, <span class="hlFld-ContribAuthor ">Nicole  White</span>, <span class="hlFld-ContribAuthor ">Ming  Yin</span>, <span class="hlFld-ContribAuthor ">Upendra A.  Argikar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 365-370. <a href="https://doi.org/10.1016/j.bmcl.2017.12.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bbased%252Bdesign%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bfrom%252Ba%252Bphenotypic%252Bscreen%26aulast%3DPalacios%26aufirst%3DDaniel%2BS.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D365%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-long  Zhang</span>, <span class="hlFld-ContribAuthor ">Tian-ying  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Shuo  Han</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Chao-yu  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure-based comparison of two NAMPT inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (2)
                                     , 294-301. <a href="https://doi.org/10.1038/aps.2017.80" title="DOI URL">https://doi.org/10.1038/aps.2017.80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.80%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DCrystal%252Bstructure-based%252Bcomparison%252Bof%252Btwo%252BNAMPT%252Binhibitors%26aulast%3DZhang%26aufirst%3DSai-long%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D2%26spage%3D294%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Curtin</span>, <span class="hlFld-ContribAuthor ">H. Robin  Heyman</span>, <span class="hlFld-ContribAuthor ">Richard F.  Clark</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Sorensen</span>, <span class="hlFld-ContribAuthor ">George A.  Doherty</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Robin R.  Frey</span>, <span class="hlFld-ContribAuthor ">Kathy A.  Sarris</span>, <span class="hlFld-ContribAuthor ">Ana L.  Aguirre</span>, <span class="hlFld-ContribAuthor ">Anurupa  Shrestha</span>, <span class="hlFld-ContribAuthor ">Noah  Tu</span>, <span class="hlFld-ContribAuthor ">Kevin  Woller</span>, <span class="hlFld-ContribAuthor ">Marina A.  Pliushchev</span>, <span class="hlFld-ContribAuthor ">Ramzi F.  Sweis</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Julie L.  Wilsbacher</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Kenton L.  Longenecker</span>, <span class="hlFld-ContribAuthor ">Diana  Raich</span>, <span class="hlFld-ContribAuthor ">Alla V.  Korepanova</span>, <span class="hlFld-ContribAuthor ">Nirupama B.  Soni</span>, <span class="hlFld-ContribAuthor ">Mikkel A.  Algire</span>, <span class="hlFld-ContribAuthor ">Paul L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Violeta L.  Marin</span>, <span class="hlFld-ContribAuthor ">Ilaria  Badagnani</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>, <span class="hlFld-ContribAuthor ">F. Greg  Buchanan</span>, <span class="hlFld-ContribAuthor ">David  Maag</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chiang</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>, <span class="hlFld-ContribAuthor ">Michael R.  Michaelides</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3317-3325. <a href="https://doi.org/10.1016/j.bmcl.2017.06.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Band%252Bcharacterization%252Bof%252Bnon-substrate%252Bisoindoline%252Burea%252Binhibitors%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DCurtin%26aufirst%3DMichael%2BL.%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3317%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie L.  Wilsbacher</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Samuel A.J.  Trammell</span>, <span class="hlFld-ContribAuthor ">Yan  Shi</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Stormy L.  Koeniger</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Yupeng  He</span>, <span class="hlFld-ContribAuthor ">Sujatha  Selvaraju</span>, <span class="hlFld-ContribAuthor ">H. Robin  Heyman</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Sorensen</span>, <span class="hlFld-ContribAuthor ">Richard F.  Clark</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Kenton L.  Longenecker</span>, <span class="hlFld-ContribAuthor ">Diana  Raich</span>, <span class="hlFld-ContribAuthor ">Alla V.  Korepanova</span>, <span class="hlFld-ContribAuthor ">Steven  Cepa</span>, <span class="hlFld-ContribAuthor ">Danli L.  Towne</span>, <span class="hlFld-ContribAuthor ">Vivek C.  Abraham</span>, <span class="hlFld-ContribAuthor ">Hua  Tang</span>, <span class="hlFld-ContribAuthor ">Paul L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Shaun M.  McLoughlin</span>, <span class="hlFld-ContribAuthor ">Ilaria  Badagnani</span>, <span class="hlFld-ContribAuthor ">Michael L.  Curtin</span>, <span class="hlFld-ContribAuthor ">Michael R.  Michaelides</span>, <span class="hlFld-ContribAuthor ">David  Maag</span>, <span class="hlFld-ContribAuthor ">F. Gregory  Buchanan</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chiang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Saul H.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Charles  Brenner</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (7)
                                     , 1236-1245. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0819" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0819%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BNovel%252BNonsubstrate%252Band%252BSubstrate%252BNAMPT%252BInhibitors%26aulast%3DWilsbacher%26aufirst%3DJulie%2BL.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D7%26spage%3D1236%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 765-768. <a href="https://doi.org/10.1016/j.bmcl.2015.12.101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bbenzothiophene%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%26aulast%3DChen%26aufirst%3DWei%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D765%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwei  Lin</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Sergio C.  Chai</span>, <span class="hlFld-ContribAuthor ">Yan  Lu</span>, <span class="hlFld-ContribAuthor ">Taosheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 505-528. <a href="https://doi.org/10.1016/j.ejmech.2015.12.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BCINPA1%252Banalogs%252Bas%252Bnovel%252Band%252Bpotent%252Binverse%252Bagonists%252Bof%252Bconstitutive%252Bandrostane%252Breceptor%26aulast%3DLin%26aufirst%3DWenwei%26date%3D2016%26volume%3D108%26spage%3D505%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Tian-Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Xin-Zhu  Liu</span>, <span class="hlFld-ContribAuthor ">Sai-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Feng  Guan</span>, <span class="hlFld-ContribAuthor ">Shu-Na  Wang</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shu  Zhuo</span>, <span class="hlFld-ContribAuthor ">Ying-Ying  Le</span>, <span class="hlFld-ContribAuthor ">Chun-Quan  Sheng</span>, <span class="hlFld-ContribAuthor ">Chao-Yu  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep12657" title="DOI URL">https://doi.org/10.1038/srep12657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep12657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep12657%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252BNovel%252BInhibitors%252Band%252BFluorescent%252BProbe%252BTargeting%252BNAMPT%26aulast%3DWang%26aufirst%3DXia%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian-Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Sai-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Dong</span>, <span class="hlFld-ContribAuthor ">Xin-Zhu  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Qun  Lv</span>, <span class="hlFld-ContribAuthor ">Qi-Jun  Qian</span>, <span class="hlFld-ContribAuthor ">Ruo-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Chun-Quan  Sheng</span>, <span class="hlFld-ContribAuthor ">Chao-Yu  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep10043" title="DOI URL">https://doi.org/10.1038/srep10043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep10043%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bnovel%252Bsmall-molecule%252Binhibitors%252Btargeting%252Bnicotinamide%252Bphosphoribosyltransferase%26aulast%3DXu%26aufirst%3DTian-Ying%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajesh A.  Rane</span>, <span class="hlFld-ContribAuthor ">Shital S.  Naphade</span>, <span class="hlFld-ContribAuthor ">Pavan Kumar  Bangalore</span>, <span class="hlFld-ContribAuthor ">Mahesh B.  Palkar</span>, <span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Mahamadhanif S.  Shaikh</span>, <span class="hlFld-ContribAuthor ">Wesam S.  Alwan</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (2)
                                     , 210-222. <a href="https://doi.org/10.1111/cbdd.12481" title="DOI URL">https://doi.org/10.1111/cbdd.12481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12481%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Bof%252BNovel%252BHybrids%252BInspired%252Bfrom%252BBromopyrrole%252BAlkaloids%252BInhibiting%252BMMP-2%252Band%252B-12%252Bas%252BAntineoplastic%252BAgents%26aulast%3DRane%26aufirst%3DRajesh%2BA.%26date%3D2015%26date%3D2014%26volume%3D86%26issue%3D2%26spage%3D210%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Tanja S.  Zabka</span>, <span class="hlFld-ContribAuthor ">Dinah L.  Misner</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>151 </em>, 16-31. <a href="https://doi.org/10.1016/j.pharmthera.2015.02.004" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DInhibition%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bin%252Bcancer%26aulast%3DSampath%26aufirst%3DDeepak%26date%3D2015%26volume%3D151%26spage%3D16%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Bang  Fu</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Guangkun  Li</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Suzanne  Tay</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 529-541. <a href="https://doi.org/10.1016/j.bmcl.2014.12.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bwith%252Bno%252Bevidence%252Bof%252BCYP3A4%252Btime-dependent%252Binhibition%252Band%252Bimproved%252Baqueous%252Bsolubility%26aulast%3DZak%26aufirst%3DMark%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D529%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Kristi  Elkins</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Mandy  Kwong</span>, <span class="hlFld-ContribAuthor ">Mary  Coons</span>, <span class="hlFld-ContribAuthor ">Bobby  Brillantes</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Thomas  O'Brien</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Belmont</span>, . </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (10)
                                     , e109366. <a href="https://doi.org/10.1371/journal.pone.0109366" title="DOI URL">https://doi.org/10.1371/journal.pone.0109366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0109366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0109366%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DStructural%252BBasis%252Bfor%252BResistance%252Bto%252BDiverse%252BClasses%252Bof%252BNAMPT%252BInhibitors%26aulast%3DWang%26aufirst%3DWeiru%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3De109366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Lulu  Yang</span>, <span class="hlFld-ContribAuthor ">Ann R  Qin</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Bianca M  Liederer</span>, <span class="hlFld-ContribAuthor ">Kirsten  Messick</span>, <span class="hlFld-ContribAuthor ">Shuguang  Ma</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Peter S  Dragovich</span>, <span class="hlFld-ContribAuthor ">Brian J  Dean</span>, <span class="hlFld-ContribAuthor ">Cornelis ECA  Hop</span>, <span class="hlFld-ContribAuthor ">Yuzhong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Measuring NAD
              +
              levels in mouse blood and tissue samples via a surrogate matrix approach using LC–MS/MS. </span><span class="cited-content_cbyCitation_journal-name">Bioanalysis</span><span> <strong>2014,</strong> <em>6 </em>
                                    (11)
                                     , 1445-1457. <a href="https://doi.org/10.4155/bio.14.8" title="DOI URL">https://doi.org/10.4155/bio.14.8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/bio.14.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fbio.14.8%26sid%3Dliteratum%253Aachs%26jtitle%3DBioanalysis%26atitle%3DMeasuring%252BNAD%252B%25252B%252Blevels%252Bin%252Bmouse%252Bblood%252Band%252Btissue%252Bsamples%252Bvia%252Ba%252Bsurrogate%252Bmatrix%252Bapproach%252Busing%252BLC%2525E2%252580%252593MS%25252FMS%26aulast%3DLiang%26aufirst%3DXiaorong%26date%3D2014%26volume%3D6%26issue%3D11%26spage%3D1445%26epage%3D1457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Xukun  Chen</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2014,</strong> <em>15 </em>
                                    (8)
                                     , 1121-1130. <a href="https://doi.org/10.1002/cbic.201402023" title="DOI URL">https://doi.org/10.1002/cbic.201402023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201402023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201402023%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DStructural%252Band%252BBiochemical%252BAnalyses%252Bof%252Bthe%252BCatalysis%252Band%252BPotency%252BImpact%252Bof%252BInhibitor%252BPhosphoribosylation%252Bby%252BHuman%252BNicotinamide%252BPhosphoribosyltransferase%26aulast%3DOh%26aufirst%3DAngela%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D8%26spage%3D1121%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Brandon  Bravo</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Guangkun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 954-962. <a href="https://doi.org/10.1016/j.bmcl.2013.12.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-based%252Bdesign%252Bof%252B3-aminopyridine-derived%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D954%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 337-343. <a href="https://doi.org/10.1016/j.bmcl.2013.11.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Befficacious%252Bcyanoguanidine-containing%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528Nampt%252529%252Binhibitors%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D337%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  O'Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Alexander  Vanderbilt</span>, <span class="hlFld-ContribAuthor ">Ann  Qin</span>, <span class="hlFld-ContribAuthor ">Lulu  Yang</span>, <span class="hlFld-ContribAuthor ">Leslie B.  Lee</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Ely  Cosino</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  LaCap</span>, <span class="hlFld-ContribAuthor ">Annie  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Simon  Williams</span>, <span class="hlFld-ContribAuthor ">Michelle  Nannini</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Peter  Jackson</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>. </span><span class="cited-content_cbyCitation_article-title">Supplementation of Nicotinic Acid with NAMPT Inhibitors Results in Loss of In Vivo Efficacy in NAPRT1-Deficient Tumor Models. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2013,</strong> <em>15 </em>
                                    (12)
                                     , 1314-IN3. <a href="https://doi.org/10.1593/neo.131718" title="DOI URL">https://doi.org/10.1593/neo.131718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.131718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.131718%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DSupplementation%252Bof%252BNicotinic%252BAcid%252Bwith%252BNAMPT%252BInhibitors%252BResults%252Bin%252BLoss%252Bof%252BIn%252BVivo%252BEfficacy%252Bin%252BNAPRT1-Deficient%252BTumor%252BModels%26aulast%3DO%2527Brien%26aufirst%3DThomas%26date%3D2013%26volume%3D15%26issue%3D12%26spage%3D1314%26epage%3DIN3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Paul  Bauer</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Yezhen  Feng</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Jarrod  Tremayne</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Guangxing  Yang</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (20)
                                     , 5488-5497. <a href="https://doi.org/10.1016/j.bmcl.2013.08.074" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bamides%252Bderived%252Bfrom%252B1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine-5-carboxylic%252Bacid%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2013%26volume%3D23%26issue%3D20%26spage%3D5488%26epage%3D5497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (17)
                                     , 4875-4885. <a href="https://doi.org/10.1016/j.bmcl.2013.06.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.06.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.06.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.06.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B2%25252C3-dihydro-1H-pyrrolo%25255B3%25252C4-c%25255Dpyridine-derived%252Bureas%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4875%26epage%3D4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Paul  Bauer</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Bang  Fu</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Sophie  Mukadam</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Jasleen  Sodhi</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (12)
                                     , 3531-3538. <a href="https://doi.org/10.1016/j.bmcl.2013.04.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Befficacious%252Burea-containing%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bwith%252Breduced%252BCYP2C9%252Binhibition%252Bproperties%26aulast%3DGunzner-Toste%26aufirst%3DJanet%26date%3D2013%26volume%3D23%26issue%3D12%26spage%3D3531%26epage%3D3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Nampt catalyzed biochemical reaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of NAD biosynthetic pathways found in mammalian cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reported Nampt inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Slice through the cocrystal structure of <b>1</b> (yellow) in complex with Nampt (important residues and solvent-excluded-surface in gray) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ">2GVJ</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The crystallographically determined locations of the Nampt substrates NAM (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5C">2E5C</a>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and PRPP (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5D">2E5D</a>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> are also shown (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Nampt crystal structure depicting virtual fragments which comprise CS-Map consensus sites (carbons in green) and derived pharmacophore points (gray spheres). A = pyridine, B = hydrogen bond acceptor, C = hydrogen bond donor, D = any ring, E = any polar atom, F = any polar atom. Sphere sizes indicate radius of each point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Co-crystal structure of compound <b>5</b> (green) in complex with Nampt. The ligand binds to a site formed by the interface of two Nampt protein monomers (depicted as white and cyan, respectively). Water molecules are depicted as red spheres, and possible hydrogen bonds are indicated with dashed orange lines. Hydrogen bonds which do not interact with the ligand, either directly or via a water molecule, are not shown. The resolution of the structure is 1.9 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic representation of the binding mode of compound <b>5</b> to Nampt. Waters are depicted as “W” and hydrogen bonds as dashed orange lines. Waters and hydrogen bonds which do not interact with the ligand are not shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nampt inhibitor general structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Left panel: compound <b>50</b> in vivo efficacy results in A2780 human ovarian carcinoma tumor xenograft model. Right panel: body weight loss as a result of compound <b>50</b> administration in xenograft experiment. Data reflect mean values (±standard deviation) of 8 animals in each group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. LC/MS/MS chromatograms of compound <b>50</b> enzyme reaction mixture: (a) multiple reaction monitoring (MRM) of transition from <i>m</i>/<i>z</i> 615.2 (adduct M + H ion) to 403.2 (parent M + H ion) indicating presence of phosphoribosylated adduct (b) MRM of transition from <i>m</i>/<i>z</i> 403.2 (parent M + H ion) to 135.1 (representing fragmentation of the left-hand side of the parent) indicating presence of both parent (<b>50</b>) and phosphoribosylated adduct. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effects of varying NAM concentrations on the ability of selected compounds to inhibit Nampt biochemical activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Urea Derivatives Synthesis: Isocyanate Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) THF, −20 to 25 °C, 2 h, 32–95% yield; (ii) THF, 25 °C, 1 h, 14–60% yield; (iii) toluene–CH<sub>2</sub>Cl<sub>2</sub>–DMA, 25–50 °C, 18 h, 17–60% yield; (iv) Na<sub>2</sub>SO<sub>3</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, 80 °C, 3 h, 23% yield; (v) Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, DMSO, 60 °C, 16 h, 31% yield; (vi) LiOH, MeOH, 25 °C, 16 h, 58% yield; (vii) piperidine, BOP, Et<sub>3</sub>N, DMA, 25 °C, 6 h, 45% yield.</p></p></figure><figure data-id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Urea and Carbamate Derivatives Synthesis: Triphosgene Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) triphosgene, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> −10 to 25 °C, 16 h, 16–92% yield; (ii) mCPBA, CH<sub>2</sub>Cl<sub>2</sub>–MeOH, 25 °C, 16 h, 15% yield; (iii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 16 h, 58% yield.</p></p></figure><figure data-id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Urea and Carbamate Derivatives Synthesis: Chloroformate Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-nitrophenyl chloroformate, toluene, 85 °C, 3 h, 100% yield; (ii) phenyl chloroformate, THF, 25 °C, 20 min, 86% yield; (iii) EtOH, reflux, 3 h, 27% yield; (iv) Et<sub>3</sub>N, 1,4-dioxane, 60 °C, 1 h, 61–96% yield.</p></p></figure><figure data-id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>30</b> and <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 4 h, 33–52% yield.</p></p></figure><figure data-id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/medium/jm-2013-00186h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400186h/production/images/large/jm-2013-00186h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400186h&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 12 h, 69% yield; (ii) Et<sub>3</sub>N, CH<sub>3</sub>CN, 80 °C, 16 h, 14% yield.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">50754</span><span class="NLM_x">–</span> <span class="NLM_lpage">50763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=50754-50763&author=J.+R.+Revolloauthor=A.+A.+Grimmauthor=S.+Imai&title=The+NAD+biosynthesis+pathway+mediated+by+nicotinamide+phosphoribosyltransferase+regulates+Sir2+activity+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DGrimm%26aufirst%3DA.%2BA.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DThe%2520NAD%2520biosynthesis%2520pathway%2520mediated%2520by%2520nicotinamide%2520phosphoribosyltransferase%2520regulates%2520Sir2%2520activity%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D50754%26epage%3D50763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rongvaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span> </span><span class="NLM_article-title">The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8-11&author=M.+Galliauthor=F.+Van+Goolauthor=A.+Rongvauxauthor=F.+Andrisauthor=O.+Leo&title=The+nicotinamide+phosphoribosyltransferase%3A+a+molecular+link+between+metabolism%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DRongvaux%26aufirst%3DA.%26aulast%3DAndris%26aufirst%3DF.%26aulast%3DLeo%26aufirst%3DO.%26atitle%3DThe%2520nicotinamide%2520phosphoribosyltransferase%253A%2520a%2520molecular%2520link%2520between%2520metabolism%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt: Linking NAD Biology, Metabolism and Cancer</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1016%2Fj.tem.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19109034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=130-138&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Kornerauthor=S.-I.+Imaiauthor=W.+Kiess&title=Nampt%3A+Linking+NAD+Biology%2C+Metabolism+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt: linking NAD biology, metabolism and cancer</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Koerner, Antje; Imai, Shin-ichiro; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to NMN, a key NAD intermediate.  Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biol., metab. and inflammation.  As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt also plays an important part in regulating insulin secretion in pancreatic β-cells.  Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation.  This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMtmRWd15knbVg90H21EOLACvtfcHk0lgGcgB7Q22MOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D&md5=2e6fc10db431e1963b0b827747466c53</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.-I.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%253A%2520Linking%2520NAD%2520Biology%252C%2520Metabolism%2520and%2520Cancer%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Belenky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">NAD<sup>+</sup> metabolism in health and disease</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=12-19&author=P.+Belenkyauthor=K.+L.+Boganauthor=C.+Brenner&title=NAD%2B+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelenky%26aufirst%3DP.%26aulast%3DBogan%26aufirst%3DK.%2BL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DNAD%252B%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2007%26volume%3D32%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zaremba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulthard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1038%2Fsj.bjc.6605166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19568233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=256-262&author=T.+Zarembaauthor=P.+Ketzerauthor=M.+Coleauthor=S.+Coulthardauthor=E.+R.+Plummerauthor=N.+J.+Curtin&title=Poly%28ADP-ribose%29+polymerase-1+polymorphisms%2C+expression+and+activity+in+selected+human+tumour+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span></div><div class="casAuthors">Zaremba, T.; Ketzer, P.; Cole, M.; Coulthard, S.; Plummer, E. R.; Curtin, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding enzyme activated by DNA breaks and involved in DNA repair and other cellular processes.  Poly(ADP-ribose) polymerase activity can be higher in cancer than in adjacent normal tissue, but cancer predisposition is reported to be greater in individuals with a single-nucleotide polymorphism (SNP) V762A (T2444C) in the catalytic domain that reduces PARP-1 activity.  Methods: To resolve these divergent observations, we detd. PARP-1 polymorphisms, PARP-1 protein expression and activity in a panel of 19 solid and haematol., adult and pediatric human cancer cell lines.  Results: There was a wide variation in PARP activity in the cell line panel (coeff. of variation, CV=103%), with the lowest and the highest activity being 2460 pmol PAR/106 (HS-5 cells) and 85 750 pmol PAR/106 (NGP cells).  Lower variation (CV=32%) was obsd. in PARP-1 protein expression with the lowest expression being 2.0 ng μg-1 (HS-5 cells) and the highest being 7.1 ng μg-1 (ML-1 cells).  The mean activity in the cancer cells was 45-fold higher than the mean activity in normal human lymphocytes and the PARP-1 protein levels were 23-fold higher.  Conclusions: Surprisingly, there was no significant correlation between PARP activity and PARP-1 protein level or the investigated polymorphisms, T2444C and CA.  British Journal of Cancer (2009) 101, 256-262; doi:10.1038/sj.bjc.6605166 www.bjcancer.com Published online 30 June 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiXp9dmBsH7Vg90H21EOLACvtfcHk0lgJWFAwuez1nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D&md5=2e8cbeef3e92351d2afd5bed60ad77d4</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605166%26sid%3Dliteratum%253Aachs%26aulast%3DZaremba%26aufirst%3DT.%26aulast%3DKetzer%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DM.%26aulast%3DCoulthard%26aufirst%3DS.%26aulast%3DPlummer%26aufirst%3DE.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520polymorphisms%252C%2520expression%2520and%2520activity%2520in%2520selected%2520human%2520tumour%2520cell%2520lines%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouhar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1517%2F14728222.11.5.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=17465726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=695-705&author=J.+A.+Khanauthor=F.+Forouharauthor=X.+Taoauthor=L.+Tong&title=Nicotinamide+adenine+dinucleotide+metabolism+as+an+attractive+target+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span></div><div class="casAuthors">Khan, Javed A.; Forouhar, Farhad; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-705</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  NAD (NAD+) has crucial roles in many cellular processes, both as a coenzyme for redox reactions and as a substrate to donate ADP-ribose units.  Enzymes involved in NAD+ metab. are attractive targets for drug discovery against a variety of human diseases, including cancer, multiple sclerosis, neurodegeneration and Huntington's disease.  A small-mol. inhibitor of nicotinamide phosphoribosyltransferase, an enzyme in the salvage pathway of NAD+ biosynthesis, is presently in clin. trials against cancer.  An analog of a kynurenine pathway intermediate is efficacious against multiple sclerosis in an animal model.  Indoleamine 2,3-dioxygenase plays an important role in immune evasion by cancer cells and other disease processes.  Inhibitors against kynurenine 3-hydroxylase can reduce the prodn. of neurotoxic metabolites while increasing the prodn. of neuroprotective compds.  This review summarizes the existing knowledge on NAD+ metabolic enzymes, with emphasis on their relevance for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrpVwpXgPHrVg90H21EOLACvtfcHk0lgJWFAwuez1nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D&md5=43a4c12a1a780feddd233e1d8209f3f6</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.5.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.5.695%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DForouhar%26aufirst%3DF.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DNicotinamide%2520adenine%2520dinucleotide%2520metabolism%2520as%2520an%2520attractive%2520target%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D695%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Koppenol, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounds, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Otto Warburg’s contributions to current concepts of cancer metabolism</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1038%2Fnrc3038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=21508971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=325-337&author=W.+H.+Koppenolauthor=P.+L.+Boundsauthor=C.+V.+Dang&title=Otto+Warburg%E2%80%99s+contributions+to+current+concepts+of+cancer+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Otto Warburg's contributions to current concepts of cancer metabolism</span></div><div class="casAuthors">Koppenol, Willem H.; Bounds, Patricia L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">325-337</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Otto Warburg pioneered quant. investigations of cancer cell metab., as well as photosynthesis and respiration.  Warburg and co-workers showed in the 1920s that, under aerobic conditions, tumor tissues metabolize approx. tenfold more glucose to lactate in a given time than normal tissues, a phenomenon known as the Warburg effect.  However, this increase in aerobic glycolysis in cancer cells is often erroneously thought to occur instead of mitochondrial respiration and has been misinterpreted as evidence for damage to respiration instead of damage to the regulation of glycolysis.  In fact, many cancers exhibit the Warburg effect while retaining mitochondrial respiration.  We re-examine Warburg's observations in relation to the current concepts of cancer metab. as being intimately linked to alterations of mitochondrial DNA, oncogenes and tumor suppressors, and thus readily exploitable for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdteDUarw-PbVg90H21EOLACvtfcHk0lgJWFAwuez1nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D&md5=72988f428422daecd23b21d242aec18a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnrc3038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3038%26sid%3Dliteratum%253Aachs%26aulast%3DKoppenol%26aufirst%3DW.%2BH.%26aulast%3DBounds%26aufirst%3DP.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DOtto%2520Warburg%25E2%2580%2599s%2520contributions%2520to%2520current%2520concepts%2520of%2520cancer%2520metabolism%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D325%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Metabolic reprogramming: a cancer hallmark even warburg did not anticipate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1016%2Fj.ccr.2012.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=22439925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=297-308&author=P.+S.+Wardauthor=C.+B.+Thompson&title=Metabolic+reprogramming%3A+a+cancer+hallmark+even+warburg+did+not+anticipate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate</span></div><div class="casAuthors">Ward, Patrick S.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-308</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer metab. has long been equated with aerobic glycolysis, seen by early biochemists as primitive and inefficient.  Despite these early beliefs, the metabolic signatures of cancer cells are not passive responses to damaged mitochondria but result from oncogene-directed metabolic reprogramming required to support anabolic growth.  Recent evidence suggests that metabolites themselves can be oncogenic by altering cell signaling and blocking cellular differentiation.  No longer can cancer-assocd. alterations in metab. be viewed as an indirect response to cell proliferation and survival signals.  We contend that altered metab. has attained the status of a core hallmark of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFCvg4k-_m7Vg90H21EOLACvtfcHk0lgJWFAwuez1nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D&md5=8e991ba77d1bb0b57c3009b6bc39ee99</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DMetabolic%2520reprogramming%253A%2520a%2520cancer%2520hallmark%2520even%2520warburg%2520did%2520not%2520anticipate%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D297%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cerna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. S.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by the small molecule GMX1778 regulates ROS-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">22408</span><span class="NLM_x">–</span> <span class="NLM_lpage">22417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=22408-22417&author=D.+Cernaauthor=H.+Liauthor=S.+Flahertyauthor=N.+Takebeauthor=C.+N.+Colemanauthor=S.+S.+Yoo&title=Inhibition+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+activity+by+the+small+molecule+GMX1778+regulates+ROS-mediated+cytotoxicity+in+a+p53-+and+nicotinic+acid+phosphoribosyltransferase1+%28NAPRT1%29-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerna%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DFlaherty%26aufirst%3DS.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DColeman%26aufirst%3DC.%2BN.%26aulast%3DYoo%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520activity%2520by%2520the%2520small%2520molecule%2520GMX1778%2520regulates%2520ROS-mediated%2520cytotoxicity%2520in%2520a%2520p53-%2520and%2520nicotinic%2520acid%2520phosphoribosyltransferase1%2520%2528NAPRT1%2529-dependent%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D22408%26epage%3D22417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0li7pKh-BKTyvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Biedermann, E.; Hasmann, M.; Loser, R.; Rattel, B.; Reiter, F.; Schein, B.; Seibel, K.; Vogt, K.</span><span> </span><span class="NLM_article-title">Preparation and formulation of pyridine derivatives as antitumor agents and immunosuppressants</span>. WO 9748397,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=E.+Biedermann&author=M.+Hasmann&author=R.+Loser&author=B.+Rattel&author=F.+Reiter&author=B.+Schein&author=K.+Seibel&author=K.+Vogt&title=Preparation+and+formulation+of+pyridine+derivatives+as+antitumor+agents+and+immunosuppressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiedermann%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520formulation%2520of%2520pyridine%2520derivatives%2520as%2520antitumor%2520agents%2520and%2520immunosuppressants%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauske, A.-R.</span><span> </span><span class="NLM_article-title">The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=45-51&author=K.+Holenauthor=L.+B.+Saltzauthor=E.+Hollywoodauthor=K.+Burkauthor=A.-R.+Hanauske&title=The+pharmacokinetics%2C+toxicities%2C+and+biologic+effects+of+FK866%2C+a+nicotinamide+adenine+dinucleotide+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DHollywood%26aufirst%3DE.%26aulast%3DBurk%26aufirst%3DK.%26aulast%3DHanauske%26aufirst%3DA.-R.%26atitle%3DThe%2520pharmacokinetics%252C%2520toxicities%252C%2520and%2520biologic%2520effects%2520of%2520FK866%252C%2520a%2520nicotinamide%2520adenine%2520dinucleotide%2520biosynthesis%2520inhibitor%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottosen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">Novel cyanoguanidines with potent oral antitumor activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3095-3100&author=C.+Schouauthor=E.+R.+Ottosenauthor=H.+J.+Petersenauthor=F.+Bjorklingauthor=S.+Latiniauthor=P.+V.+Hjarnaaauthor=E.+Brammauthor=L.+Binderup&title=Novel+cyanoguanidines+with+potent+oral+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchou%26aufirst%3DC.%26aulast%3DOttosen%26aufirst%3DE.%2BR.%26aulast%3DPetersen%26aufirst%3DH.%2BJ.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DNovel%2520cyanoguanidines%2520with%2520potent%2520oral%2520antitumor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3095%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ravaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3weeks in solid tumours: An ECSG/EORTC study</span> <span class="citation_source-journal">Eur. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=702-707&author=A.+Ravaudauthor=T.+Cernyauthor=C.+Terretauthor=J.+Wandersauthor=B.+N.+Buiauthor=D.+Hessauthor=J.-P.+Drozauthor=P.+Fumoleauauthor=C.+Twelves&title=Phase+I+study+and+pharmacokinetic+of+CHS-828%2C+a+guanidino-containing+compound%2C+administered+orally+as+a+single+dose+every+3weeks+in+solid+tumours%3A+An+ECSG%2FEORTC+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavaud%26aufirst%3DA.%26aulast%3DCerny%26aufirst%3DT.%26aulast%3DTerret%26aufirst%3DC.%26aulast%3DWanders%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DB.%2BN.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DDroz%26aufirst%3DJ.-P.%26aulast%3DFumoleau%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520study%2520and%2520pharmacokinetic%2520of%2520CHS-828%252C%2520a%2520guanidino-containing%2520compound%252C%2520administered%2520orally%2520as%2520a%2520single%2520dose%2520every%25203weeks%2520in%2520solid%2520tumours%253A%2520An%2520ECSG%252FEORTC%2520study%26jtitle%3DEur.%2520J.%2520Cancer.%26date%3D2005%26volume%3D41%26spage%3D702%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hovstadium, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissmeyer, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasilnikoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonnebo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, J.</span><span> </span><span class="NLM_article-title">A phase I study of CHS 828 in patients with solid tumor malignancy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=12231525" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2843-2850&author=P.+Hovstadiumauthor=R.+Larssonauthor=E.+Jonssonauthor=T.+Skovauthor=A.-M.+Kissmeyerauthor=K.+Krasilnikoffauthor=J.+Berghauthor=M.+O.+Karlssonauthor=A.+Lonneboauthor=J.+Ahlgren&title=A+phase+I+study+of+CHS+828+in+patients+with+solid+tumor+malignancy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHovstadium%26aufirst%3DP.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DKissmeyer%26aufirst%3DA.-M.%26aulast%3DKrasilnikoff%26aufirst%3DK.%26aulast%3DBergh%26aufirst%3DJ.%26aulast%3DKarlsson%26aufirst%3DM.%2BO.%26aulast%3DLonnebo%26aufirst%3DA.%26aulast%3DAhlgren%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520CHS%2520828%2520in%2520patients%2520with%2520solid%2520tumor%2520malignancy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D2843%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Galli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carraro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasi Roman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=771-779&author=U.+Galliauthor=E.+Ercolanoauthor=L.+Carraroauthor=C.+R.+Blasi+Romanauthor=G.+Sorbaauthor=P.+L.+Canonicoauthor=A.+A.+Genazzaniauthor=G.+C.+Tronauthor=R.+A.+Billington&title=Synthesis+and+biological+evaluation+of+isosteric+analogues+of+FK866%2C+an+inhibitor+of+NAD+salvage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26aulast%3DErcolano%26aufirst%3DE.%26aulast%3DCarraro%26aufirst%3DL.%26aulast%3DBlasi%2BRoman%26aufirst%3DC.%2BR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DBillington%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520isosteric%2520analogues%2520of%2520FK866%252C%2520an%2520inhibitor%2520of%2520NAD%2520salvage%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D771%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Willardsen, A. J.; Lockman, J. W.; Murphy, B. R.; Judd, W. R.; Kim, I. C.; Kim, S.-H.; Zigar, D. F.; Yager, K. M.; Fleischer, T. C.; Terry-Lorenzo, R. T.; Boniface, J. J.; Parker, D. P.; McAlexander, I. A.; Bursavich, M. G.; Dastrup, D. M.</span><span> </span><span class="NLM_article-title">Compounds and therapeutic uses thereof</span>. WO 2011109441,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+J.+Willardsen&author=J.+W.+Lockman&author=B.+R.+Murphy&author=W.+R.+Judd&author=I.+C.+Kim&author=S.-H.+Kim&author=D.+F.+Zigar&author=K.+M.+Yager&author=T.+C.+Fleischer&author=R.+T.+Terry-Lorenzo&author=J.+J.+Boniface&author=D.+P.+Parker&author=I.+A.+McAlexander&author=M.+G.+Bursavich&author=D.+M.+Dastrup&title=Compounds+and+therapeutic+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWillardsen%26aufirst%3DA.%2BJ.%26atitle%3DCompounds%2520and%2520therapeutic%2520uses%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lockman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zigar, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattum, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry-Lorenzo, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischer, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span> </span><span class="NLM_article-title">Analogues of 4-[(7-bromo-2-methyl-4-oxo-3<i>H</i>-quinazolin-6-yl)methylprop-2-ynylamino]-<i>N</i>-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8734</span><span class="NLM_x">–</span> <span class="NLM_lpage">8746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101145b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8734-8746&author=J.+W.+Lockmanauthor=B.+R.+Murphyauthor=D.+F.+Zigarauthor=W.+R.+Juddauthor=P.+M.+Slattumauthor=Z.-H.+Gaoauthor=K.+Ostaninauthor=J.+Greenauthor=R.+McKinnonauthor=R.+T.+Terry-Lorenzoauthor=T.+C.+Fleischerauthor=J.+J.+Bonifaceauthor=M.+Shenderovichauthor=J.+A.+Willardsen&title=Analogues+of+4-%5B%287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%29methylprop-2-ynylamino%5D-N-%283-pyridylmethyl%29benzamide+%28CB-30865%29+as+potent+inhibitors+of+nicotinamide+phosphoribosyltransferase+%28Nampt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm101145b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101145b%26sid%3Dliteratum%253Aachs%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DMurphy%26aufirst%3DB.%2BR.%26aulast%3DZigar%26aufirst%3DD.%2BF.%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DGao%26aufirst%3DZ.-H.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DTerry-Lorenzo%26aufirst%3DR.%2BT.%26aulast%3DFleischer%26aufirst%3DT.%2BC.%26aulast%3DBoniface%26aufirst%3DJ.%2BJ.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DAnalogues%2520of%25204-%255B%25287-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl%2529methylprop-2-ynylamino%255D-N-%25283-pyridylmethyl%2529benzamide%2520%2528CB-30865%2529%2520as%2520potent%2520inhibitors%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8734%26epage%3D8746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kumar, D. V.; Slattum, P. M.; Yager, K. M.; Shenderovich, M. D.; Tangallapally, R.; Kim, S.</span><span> </span><span class="NLM_article-title">Compounds and therapeutic uses thereof</span>. WO 2012177782,<span class="NLM_x"> </span><span class="NLM_year">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+V.+Kumar&author=P.+M.+Slattum&author=K.+M.+Yager&author=M.+D.+Shenderovich&author=R.+Tangallapally&author=S.+Kim&title=Compounds+and+therapeutic+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DD.%2BV.%26atitle%3DCompounds%2520and%2520therapeutic%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Jegham, S.; Arigon, J.; Combet, R.; Hilairet, S.; Fraisse, P.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic use thereof</span>. US 20100222319,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=S.+Jegham&author=J.+Arigon&author=R.+Combet&author=S.+Hilairet&author=P.+Fraisse&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Duclos, O.; Bernhart, J. M.; Jegham, S.; McCort, G.</span><span> </span><span class="NLM_article-title">Antineoplastic derivatives, preparation thereof, and therapeutic use thereof</span>. WO 2010004198,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=O.+Duclos&author=J.+M.+Bernhart&author=S.+Jegham&author=G.+McCort&title=Antineoplastic+derivatives%2C+preparation+thereof%2C+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DAntineoplastic%2520derivatives%252C%2520preparation%2520thereof%252C%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bouaboula, M.; Combet, R.; Jegham, S.; Hilairet, S.</span><span> </span><span class="NLM_article-title">Anticancer compounds, preparation thereof, and therapeutic use thereof</span>. WO 2010109115,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Arigon&author=C.+Bernhart&author=M.+Bouaboula&author=R.+Combet&author=S.+Jegham&author=S.+Hilairet&title=Anticancer+compounds%2C+preparation+thereof%2C+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DAnticancer%2520compounds%252C%2520preparation%2520thereof%252C%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bouaboula, M.; Combet, R.; Hilairet, S.; Jegham, S.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic use thereof as anticancer drugs</span>. WO 2010109112,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Arigon&author=C.+Bernhart&author=M.+Bouaboula&author=R.+Combet&author=S.+Hilairet&author=S.+Jegham&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%2520as%2520anticancer%2520drugs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bouaboula, M.; Dimalta, A.; Nardi, F.; Jegham, S.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic uses thereof</span>. WO 2012038904,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Arigon&author=C.+Bernhart&author=M.+Bouaboula&author=A.+Dimalta&author=F.+Nardi&author=S.+Jegham&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520uses%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Arigon, J.; Bernhart, C.; Bosch, M.; Bouaboula, M.; Nardi, F.; Jegham, S.; Combet, R.</span><span> </span><span class="NLM_article-title">Thienopyridine nicotinamide derivatives, preparation thereof and therapeutic use thereof</span>. WO 2012038905,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Arigon&author=C.+Bernhart&author=M.+Bosch&author=M.+Bouaboula&author=F.+Nardi&author=S.+Jegham&author=R.+Combet&title=Thienopyridine+nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArigon%26aufirst%3DJ.%26atitle%3DThienopyridine%2520nicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Curtin, M. L.; Sorensen, B. K.; Heyman, H. R.; Clark, R. F.; Woller, K. R.; Shah, O. J.; Michaelides, Mi.; Tse, C.; Vasudevan, A.; Mack, H.; Hansen, T. M.; Sweis, R.; Pliushchev, M. A.</span><span> </span><span class="NLM_article-title">Dihydroisoindolecarboxamide derivatives as NAMPT and ROCK inhibitors and their preparation</span>. US 20120122842,<span class="NLM_x"> </span><span class="NLM_year">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+L.+Curtin&author=B.+K.+Sorensen&author=H.+R.+Heyman&author=R.+F.+Clark&author=K.+R.+Woller&author=O.+J.+Shah&author=Mi.+Michaelides&author=C.+Tse&author=A.+Vasudevan&author=H.+Mack&author=T.+M.+Hansen&author=R.+Sweis&author=M.+A.+Pliushchev&title=Dihydroisoindolecarboxamide+derivatives+as+NAMPT+and+ROCK+inhibitors+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26atitle%3DDihydroisoindolecarboxamide%2520derivatives%2520as%2520NAMPT%2520and%2520ROCK%2520inhibitors%2520and%2520their%2520preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Curtin, M. L.; Sorensen, B. K.; Heyman, H. R.; Clark, R. F.; Michaelides, M.; Tse, C.</span><span> </span><span class="NLM_article-title">NAMPT inhibitors as therapeutic agents for the treatment of diseases</span>US 20120122924,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+L.+Curtin&author=B.+K.+Sorensen&author=H.+R.+Heyman&author=R.+F.+Clark&author=M.+Michaelides&author=C.+Tse&title=NAMPT+inhibitors+as+therapeutic+agents+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26atitle%3DNAMPT%2520inhibitors%2520as%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">13748</span><span class="NLM_x">–</span> <span class="NLM_lpage">13753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=13748-13753&author=E.+S.+Burgosauthor=M.-C.+Hoauthor=S.+C.+Almoauthor=V.+L.+Schramm&title=A+phosphoenzyme+mimic%2C+overlapping+catalytic+sites+and+reaction+coordinate+motion+for+human+NAMPT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DHo%26aufirst%3DM.-C.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DA%2520phosphoenzyme%2520mimic%252C%2520overlapping%2520catalytic%2520sites%2520and%2520reaction%2520coordinate%2520motion%2520for%2520human%2520NAMPT%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D13748%26epage%3D13753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vajda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarnieri, F.</span><span> </span><span class="NLM_article-title">Characterization of protein–ligand interaction sites using experimental and computational methods</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=363-369&author=S.+Vajdaauthor=F.+Guarnieri&title=Characterization+of+protein%E2%80%93ligand+interaction+sites+using+experimental+and+computational+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVajda%26aufirst%3DS.%26aulast%3DGuarnieri%26aufirst%3DF.%26atitle%3DCharacterization%2520of%2520protein%25E2%2580%2593ligand%2520interaction%2520sites%2520using%2520experimental%2520and%2520computational%2520methods%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">CS-Map distributes solvent like probe molecules over the protein surface, minimizes their energy independently, clusters the resulting probe positions, and ranks the clusters thereby identifying sites where probes consistently bind.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CS-Map+distributes+solvent+like+probe+molecules+over+the+protein+surface%2C+minimizes+their+energy+independently%2C+clusters+the+resulting+probe+positions%2C+and+ranks+the+clusters+thereby+identifying+sites+where+probes+consistently+bind."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Landon, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancia, D. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajda, S.</span><span> </span><span class="NLM_article-title">Identification of hot spots within druggable binding regions by computational solvent mapping of proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061134b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1231-1240&author=M.+R.+Landonauthor=D.+R.+Lanciaauthor=J.+Yuauthor=S.+C.+Thielauthor=S.+Vajda&title=Identification+of+hot+spots+within+druggable+binding+regions+by+computational+solvent+mapping+of+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Hot Spots within Druggable Binding Regions by Computational Solvent Mapping of Proteins</span></div><div class="casAuthors">Landon, Melissa R.; Lancia, David R., Jr.; Yu, Jessamin; Thiel, Spencer C.; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1231-1240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here the authors apply the computational solvent mapping (CS-Map) algorithm toward the in silico identification of hot spots, i.e., regions of protein binding sites that are major contributors to the binding energy and, hence, are prime targets in drug design.  The CS-Map algorithm, developed for binding site characterization, moves small org. functional groups around the protein surface and dets. their most energetically favorable binding positions.  The utility of CS-Map algorithm toward the prediction of hot spot regions in druggable binding pockets is illustrated by three test systems: (1) renin aspartic protease, (2) a set of previously characterized druggable proteins, and (3) E. coli ketopantoate reductase.  In each of the three studies, existing literature was used to verify the results.  Based on the authors analyses, the authors conclude that the information provided by CS-Map can contribute substantially to the identification of hot spots, a necessary predecessor of fragment-based drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVim9shdtBbVg90H21EOLACvtfcHk0lhPfdwHQRytAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWisrw%253D&md5=2d6a0678acdb2dd45fed73b05229bd03</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm061134b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061134b%26sid%3Dliteratum%253Aachs%26aulast%3DLandon%26aufirst%3DM.%2BR.%26aulast%3DLancia%26aufirst%3DD.%2BR.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DThiel%26aufirst%3DS.%2BC.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520hot%2520spots%2520within%2520druggable%2520binding%2520regions%2520by%2520computational%2520solvent%2520mapping%2520of%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1231%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span> <span class="citation_source-journal">Nature Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1038%2Fnsmb1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=16783377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=582-588&author=J.+A.+Khanauthor=X.+Taoauthor=L.+Tong&title=Molecular+basis+for+the+inhibition+of+human+NMPRTase%2C+a+novel+target+for+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span></div><div class="casAuthors">Khan, Javed A.; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors.  The authors have detd. the crystal structures at up to 2.1-Å resoln. of human and murine NMPRTase, alone and in complex with the reaction product NMN or the inhibitor FK866.  The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies.  FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866.  Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate.  Our structural and biochem. studies provide a starting point for the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s-XY1uB70LVg90H21EOLACvtfcHk0li42hasCYWeiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D&md5=debef567dbcf629422472ef1b63dc396</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1105%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520inhibition%2520of%2520human%2520NMPRTase%252C%2520a%2520novel%2520target%2520for%2520anticancer%2520agents%26jtitle%3DNature%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D582%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span> </span><span class="NLM_article-title">Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1093%2Fjb%2Fmvp152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19819904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1KgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2010&pages=95-107&author=R.+Takahashiauthor=S.+Nakamuraauthor=T.+Nakazawaauthor=K.+Minouraauthor=T.+Yoshidaauthor=Y.+Nishiauthor=Y.+Kobayashiauthor=T.+Ohkubo&title=Structure+and+reaction+mechanism+of+human+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase</span></div><div class="casAuthors">Takahashi, Ryo; Nakamura, Shota; Nakazawa, Takashi; Minoura, Katsuhiko; Yoshida, Takuya; Nishi, Yoshinori; Kobayashi, Yuji; Ohkubo, Tadayasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-107</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Nicotinamide (NM) phosphoribosyltransferase (NMPRTase) catalyzes the reaction of NM and 5'-phosphoribosyl-1'-pyrophosphate (PRPP) to form NMN (NMN) and pyrophosphate (PPi) in the pathway of NAD biosynthesis.  Monitoring the 1H and 31P NMR spectra of the reaction mixt., it was found that this reaction was reversible as dictated by the equil. const., K = [NMN][PPi]/([NM][PRPP]) = 0.14, which agreed well with the ratio of 2nd-order rate consts. for the forward and backward reactions, K = 0.16.  The crystal structures of this enzyme in the free form and bound to NM and PRPP at a resoln. of 2.0-2.2 Å were essentially identical to that of the complex with NMN, except for some variations that could facilitate the substitution reaction by fixing the nucleophile and the leaving group for the requisite inversion of configuration at the C1' carbon of the ribose ring.  In the active site near the C1' atom of the bound PRPP or NMN, there was neither neg. charged group nor waterproof environment necessary to support the feasibility of a ribo-oxocarbocation intermediate inherent in the SN1 mechanism.  The structures and catalytic mechanism thus revealed were also discussed in connection with the multiple biol. functions of NMPRTase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoryShxAcZioLVg90H21EOLACvtfcHk0li42hasCYWeiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1KgtA%253D%253D&md5=a0e2dd70ae69bce884a1d1a8fcfb4b4e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvp152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvp152%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DNakazawa%26aufirst%3DT.%26aulast%3DMinoura%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DNishi%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DOhkubo%26aufirst%3DT.%26atitle%3DStructure%2520and%2520reaction%2520mechanism%2520of%2520human%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D147%26spage%3D95%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span>EMolecules Plus screening compound library. <a href="http://www.emolecules.com" class="extLink">http://www.emolecules.com</a>. (Accessed May<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EMolecules+Plus+screening+compound+library.+http%3A%2F%2Fwww.emolecules.com.+%28Accessed+May+2010%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0li42hasCYWeiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0ljAu-NyQ4GVRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD<sup>+</sup> biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">–</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Berger&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0ljAu-NyQ4GVRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Because of the tight binding of these inhibitors and significant substrate inhibition caused by high NAM concentrations, the competitive inhibition data are presented in the manner shown as opposed to more traditional Michaelis–Menten type methods (i.e., 1/<i>V</i> vs 1/Substrate plots). See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for additional details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400186h&amp;key=10.1002%2F0471220639" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+A.+Copeland&title=Enzymes%3A+A+Practical+Introduction+to+Structure%2C+Mechanism%2C+and+Data+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F0471220639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEnzymes%253A%2520A%2520Practical%2520Introduction%2520to%2520Structure%252C%2520Mechanism%252C%2520and%2520Data%2520Analysis%26pub%3DWiley-VCH%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">The media employed for the cell culture experiments contained 8 μM NAM. Intracellular NAM concentrations were not measured in these experiments.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">The ability of NAM to attenuate the cell potency of Nampt inhibitors has been previously described in the literature:</p></div><span class="NLM_contrib-group">Hasmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemainda, I.</span><span> </span><span class="NLM_article-title">FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7436</span><span class="NLM_x">–</span> <span class="NLM_lpage">7442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400186h&amp;key=14612543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400186h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7436-7442&author=M.+Hasmannauthor=I.+Schemainda&title=FK866%2C+a+highly+specific+noncompetitive+inhibitor+of+nicotinamide+phosphoribosyltransferase%2C+represents+a+novel+mechanism+for+induction+of+tumor+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis</span></div><div class="casAuthors">Hasmann, Max; Schemainda, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7436-7442</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulation of apoptosis, the physiol. form of cell death, is closely assocd. with immunol. diseases and cancer.  Apoptosis is activated either by death receptor-driven or mitochondrial pathways, both of which may provide potential targets for novel anticancer drugs.  Although several ligands stimulating death receptors have been described, the actual mol. events triggering the mitochondrial pathway are largely unknown.  Here, we show initiation of apoptosis by gradual depletion of the intracellular coenzyme NAD+.  We identified the first low mol. wt. compd., designated FK866, which induces apoptosis by highly specific, noncompetitive inhibition of nicotinamide phosphoribosyltransferase (NAPRT), a key enzyme in the regulation of NAD+ biosynthesis from the natural precursor nicotinamide.  Interference with this enzyme does not primarily intoxicate cells because the mitochondrial respiratory activity and the NAD+-dependent redox reactions involved remain unaffected as long as NAD+ is not effectively depleted by catabolic reactions.  Certain tissues, however, have a high turnover of NAD+ through its cleavage by enzymes like poly(ADP-ribose) polymerase.  Such cells often rely on the more readily available nicotinamide pathway for NAD+ synthesis and undergo apoptosis after inhibition of NAPRT, whereas cells effectively using the nicotinic acid pathway for NAD+ synthesis remain unaffected.  In support of this concept, FK866 effectively induced delayed cell death by apoptosis in HepG2 human liver carcinoma cells with an IC50 of ∼1 nM, did not directly inhibit mitochondrial respiratory activity, but caused gradual NAD+ depletion through specific inhibition of NAPRT.  This enzyme, when partially purified from K562 human leukemia cells, was noncompetitively inhibited by FK866, and the inhibitor consts. were calcd. to be 0.4 nM for the enzyme/substrate complex (Ki) and 0.3 nM for the free enzyme (Ki'), resp.  Nicotinic acid and nicotinamide were both found to have antidote potential for the cellular effects of FK866.  FK866 may be used for treatment of diseases implicating deregulated apoptosis such as cancer for immunosuppression or as a sensitizer for genotoxic agents.  Furthermore, it may provide an important tool for investigation of the mol. triggers of the mitochondrial pathway leading to apoptosis through enabling temporal sepn. of NAD+ decrease from ATP breakdown and apoptosis by several days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAOS3LOADp6LVg90H21EOLACvtfcHk0lhkX0i3cMVeZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGltb4%253D&md5=c67fd08fdfc233ba86478967b13d19a2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasmann%26aufirst%3DM.%26aulast%3DSchemainda%26aufirst%3DI.%26atitle%3DFK866%252C%2520a%2520highly%2520specific%2520noncompetitive%2520inhibitor%2520of%2520nicotinamide%2520phosphoribosyltransferase%252C%2520represents%2520a%2520novel%2520mechanism%2520for%2520induction%2520of%2520tumor%2520cell%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7436%26epage%3D7442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The phenomenon of potent Nampt enzyme inhibition affording relatively weak cellular activity was also observed by others with a different inhibitor series (reference <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">8b</a>). The authors of this study noted that 95–96% inhibition of Nampt was required to afford good cell potency. It is likely that these observations are related to those described in the present work. Additional experiments will be required to better understand the relationships between Nampt enzyme inhibition and corresponding cellular activity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GVJ','PDB','2GVJ'); return false;">PDB: 2GVJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5C','PDB','2E5C'); return false;">PDB: 2E5C</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E5D','PDB','2E5D'); return false;">PDB: 2E5D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JR5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JR5','PDB','4JR5'); return false;">PDB: 4JR5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/jm400186h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54257"></div></div></div></div></div><hr /></hr><p class="last">Details of computational methods, details of analytical LCMS and LC/MS/MS methods, in vitro and in vivo ADME and experimental procedures, experimental details for PK and efficacy study of compound <b>50</b> in the mouse, protein expression/purification and crystallographic methods and procedures for <b>5</b> (in complex with Nampt), details of Nampt biochemical and cell-based assays. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400186h/suppl_file/jm400186h_si_001.pdf">jm400186h_si_001.pdf (552.89 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JR5">4JR5</a> for <b>5</b> complexed with Nampt.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400186h&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm400186h%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400186h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992080cf9bd1fb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
